<!DOCTYPE article
 PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2 20190208//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="preprint"><?all-math-mml yes?><?use-mml?><?origin ukpmcpa?><front><journal-meta><journal-id journal-id-type="nlm-ta">bioRxiv</journal-id><journal-title-group><journal-title>bioRxiv : the preprint server for biology</journal-title></journal-title-group><issn pub-type="ppub"/></journal-meta><article-meta><article-id pub-id-type="manuscript">EMS162965</article-id><article-id pub-id-type="doi">10.1101/2021.10.25.465646</article-id><article-id pub-id-type="archive">PPR410848</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group><subj-group subj-group-type="europepmc-category"><subject>Covid-19</subject></subj-group></article-categories><title-group><article-title>Structure, receptor recognition and antigenicity of the human coronavirus CCoV-HuPn-2018 spike glycoprotein</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Tortorici</surname><given-names>M. Alejandra</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Walls</surname><given-names>Alexandra C.</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Joshi</surname><given-names>Anshu</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Park</surname><given-names>Young-Jun</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Eguia</surname><given-names>Rachel T.</given-names></name><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author"><name><surname>Stevens-Ayers</surname><given-names>Terry</given-names></name><xref ref-type="aff" rid="A3">3</xref></contrib><contrib contrib-type="author"><name><surname>Boeckh</surname><given-names>Michael J.</given-names></name><xref ref-type="aff" rid="A3">3</xref></contrib><contrib contrib-type="author"><name><surname>Telenti</surname><given-names>Amalio</given-names></name><xref ref-type="aff" rid="A4">4</xref></contrib><contrib contrib-type="author"><name><surname>Lanzavecchia</surname><given-names>Antonio</given-names></name><xref ref-type="aff" rid="A5">5</xref><xref ref-type="aff" rid="A6">6</xref></contrib><contrib contrib-type="author"><name><surname>Corti</surname><given-names>Davide</given-names></name><xref ref-type="aff" rid="A6">6</xref></contrib><contrib contrib-type="author"><name><surname>Bloom</surname><given-names>Jesse D.</given-names></name><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author"><name><surname>Veesler</surname><given-names>David</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="corresp" rid="CR1">*</xref></contrib></contrib-group><aff id="A1"><label>1</label>Department of Biochemistry, University of Washington, Seattle, WA 98195, USA</aff><aff id="A2"><label>2</label>Basic Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA</aff><aff id="A3"><label>3</label>Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA</aff><aff id="A4"><label>4</label>Vir Biotechnology, San Francisco, CA 94158, USA</aff><aff id="A5"><label>5</label>Istituto Nazionale Genetica Molecolare, 20122 Milano, Italy</aff><aff id="A6"><label>6</label>Humabs Biomed SA, a subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland</aff><author-notes><corresp id="CR1"><label>*</label>Correspondence: <email>dveesler@uw.edu</email></corresp></author-notes><pub-date pub-type="nihms-submitted"><day>20</day><month>01</month><year>2023</year></pub-date><pub-date pub-type="preprint"><day>26</day><month>10</month><year>2021</year></pub-date><permissions><ali:free_to_read/><license><ali:license_ref>https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p>This work is licensed under a <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">CC BY-NC-ND 4.0 International license</ext-link>.</license-p></license></permissions><abstract><p id="P1">The recent isolation of CCoV-HuPn-2018 from a child respiratory swab indicates that more coronaviruses are spilling over to humans than previously appreciated. Here, we determined cryo-electron microscopy structures of the CCoV-HuPn-2018 spike glycoprotein trimer in two distinct conformational states and identified that it binds canine, feline and porcine aminopeptidase N (APN encoded by <italic>ANPEP</italic>) orthologs which serve as entry receptors. Introduction of an oligosaccharide at position N739 of human APN renders cells susceptible to CCoV-HuPn-2018 spike-mediated entry, suggesting that single nucleotide polymorphisms could account for the detection of this virus in some individuals. Human polyclonal plasma antibodies elicited by HCoV-229E infection and a porcine coronavirus monoclonal antibody inhibit CCoV-HuPn-2018 S-mediated entry, indicating elicitation of cross-neutralizing activity among α-coronaviruses. These data provide a blueprint of the CCoV-HuPn-2018 infection machinery, unveil the viral entry receptor and pave the way for vaccine and therapeutic development targeting this zoonotic pathogen.</p></abstract></article-meta></front><body><sec id="S1" sec-type="intro"><title>Introduction</title><p id="P2">Four coronaviruses are endemic in humans and typically responsible for common colds: the β-coronaviruses OC43 and HKU1 and the α-coronaviruses NL63 and 229E. Moreover, three highly pathogenic β-coronaviruses have jumped from their animal hosts to humans in the last two decades: SARS-CoV, MERS-CoV and SARS-CoV-2. Both SARS-CoV and SARS-CoV-2 cluster in the sarbecovirus subgenus and originated in bats which most likely acted as reservoir hosts for these two viruses (<xref ref-type="bibr" rid="R21">Ge et al., 2013</xref>; <xref ref-type="bibr" rid="R88">Zhou et al., 2020</xref>). Whereas palm civets and racoon dogs have been recognized as intermediate hosts for zoonotic transmission of SARS-CoV between bats and humans (<xref ref-type="bibr" rid="R23">Guan et al., 2003</xref>), the SARS-CoV-2 intermediate host remains unknown. MERS-CoV was suggested to originate from bats although dromedary camels act as the reservoir host fueling spillover to humans (<xref ref-type="bibr" rid="R24">Haagmans et al., 2014</xref>; <xref ref-type="bibr" rid="R41">Memish et al., 2013</xref>). Recurrent coronavirus zoonoses along with detection of numerous coronaviruses in wildlife suggest that cross-species transmission events will continue to occur (<xref ref-type="bibr" rid="R2">Anthony et al., 2017</xref>; <xref ref-type="bibr" rid="R42">Menachery et al., 2015</xref>, <xref ref-type="bibr" rid="R43">2016</xref>, <xref ref-type="bibr" rid="R44">2020</xref>).</p><p id="P3">The coronavirus spike (S) glycoprotein folds as a homotrimer promoting viral entry into host cells (<xref ref-type="bibr" rid="R67">Tortorici and Veesler, 2019</xref>; <xref ref-type="bibr" rid="R74">Walls et al., 2016a</xref>, <xref ref-type="bibr" rid="R78">2020a</xref>). S comprises an S<sub>1</sub> subunit, which recognizes host cell receptors, and an S<sub>2</sub> subunit, that mediates fusion of the viral and cellular membranes (<xref ref-type="bibr" rid="R76">Walls et al., 2017</xref>). Therefore, S plays a key role in modulating host and tissue tropism as well as zoonotic transmission. Since the coronavirus S glycoprotein is the target of neutralizing antibodies, it is the main focus of therapeutics and vaccine development, including monoclonal antibody therapies and vaccines (<xref ref-type="bibr" rid="R3">Baum et al., 2020</xref>; <xref ref-type="bibr" rid="R11">Corbett et al., 2020</xref>; <xref ref-type="bibr" rid="R12">Corti et al., 2021</xref>; <xref ref-type="bibr" rid="R25">Hansen et al., 2020</xref>; <xref ref-type="bibr" rid="R39">McCallum et al., 2021a</xref>; <xref ref-type="bibr" rid="R51">Piccoli et al., 2020</xref>; <xref ref-type="bibr" rid="R52">Pinto et al., 2020</xref>; <xref ref-type="bibr" rid="R54">Polack et al., 2020</xref>; <xref ref-type="bibr" rid="R77">Walls et al., 2019</xref>, <xref ref-type="bibr" rid="R79">2020b</xref>, <xref ref-type="bibr" rid="R80">2021</xref>).</p><p id="P4">Viruses genetically related to canine and feline coronaviruses have been previously identified in respiratory swabs obtained from patients with pneumonia or acute respiratory symptoms in Malaysia and the US (<xref ref-type="bibr" rid="R62">Silva and Mullis, 2014</xref>; <xref ref-type="bibr" rid="R87">Xiu et al., 2020</xref>). In Malaysia, eight) of 301 (2.5%) patients hospitalized with pneumonia between 2017 and 2018 in Sarawak were positive by pan-species coronavirus semi-nested RT-PCR assay and one specimen was identified as a novel canine-feline recombinant alphacoronavirus (genotype II) that was named CCoV-HuPn-2018 (<xref ref-type="bibr" rid="R73">Vlasova et al., 2021</xref>). The coronavirus isolate was shown to be cytopathic using canine A72 cells (<xref ref-type="bibr" rid="R73">Vlasova et al., 2021</xref>). These studies suggested that zoonotic transmission occurred and that these viruses, which were not previously known to infect humans, might be associated with clinical symptoms. Furthermore, these findings point to the circulation of several more coronaviruses in humans than previously appreciated and underscore the zoonotic threats posed by members of multiple distinct coronavirus genera.</p><sec id="S2"><title>Architecture of the CCoV-HuPn-2018 S trimer</title><p id="P5">To visualize the infection machinery of the newly emerged CCoV-HuPn-2018, we characterized its S glycoprotein ectodomain trimer using cryo-electron microscopy (cryoEM). The CCoV-HuPn-2018 S trimer is ~150Å high with a triangular cross-section and comprises an N-terminal S<sub>1</sub> subunit divided into domains designated 0 and A-D as well as a C-terminal S2 subunit which contains the fusion machinery (<xref ref-type="bibr" rid="R67">Tortorici and Veesler, 2019</xref>) (<xref ref-type="fig" rid="F1">Figure 1A</xref>). 3D classification of the data revealed the presence of two distinct S conformations with domain 0 swung out (at the periphery of the trimer) or proximal, i.e. oriented toward the viral membrane (apposed directly underneath domain A) for which we determined structures at 2.8 and 3.1 Å resolution, respectively (<xref ref-type="fig" rid="F1">Figure 1B-E</xref>, <xref ref-type="supplementary-material" rid="SD1">Figure S1</xref> and <xref ref-type="supplementary-material" rid="SD1">Table S1</xref>). The latter domain 0 conformational state (‘proximal’) is similar to the one described for the S of HCoV-NL63 (<xref ref-type="bibr" rid="R75">Walls et al., 2016b</xref>) and porcine epidemic diarrhea virus (PEDV) (<xref ref-type="bibr" rid="R29">Kirchdoerfer et al., 2021</xref>) whereas the former conformation (‘swung out’) is more reminiscent of another state detected for PEDV S (<xref ref-type="bibr" rid="R84">Wrapp and McLellan, 2019</xref>) and feline infectious peritonitis virus (FIPV) (<xref ref-type="supplementary-material" rid="SD1">Figure S2</xref>). We used local refinement to overcome the conformational variability of domain 0 and obtained reconstructions at 3.1 and 3.8 Å resolution for the swung out and proximal conformational states, respectively, which are related by a rotation of 135° (<xref ref-type="fig" rid="F1">Figure 1E</xref>, <xref ref-type="supplementary-material" rid="SD1">Figure S1</xref> and <xref ref-type="supplementary-material" rid="SD1">Table S1</xref>).</p><p id="P6">The CCoV-HuPn-2018 S trimer is densely decorated with oligosaccharides distributed in both the S<sub>1</sub> and S<sub>2</sub> subunits. In total, 24 glycans out of 32 putative N-linked glycosylation sequons are resolved to different extents in at least one of the two cryoEM maps (<xref ref-type="fig" rid="F1">Figure 1B-E</xref> and <xref ref-type="supplementary-material" rid="SD1">Table S2</xref>). The S<sub>1</sub> subunit structure is most similar to NL63 and 229E S whereas the S<sub>2</sub> subunit architecture is most closely related to PEDV and FIPV S, supporting the possibility that the CCoV-HuPn-2018 S gene arose from a recombination event (<xref ref-type="bibr" rid="R73">Vlasova et al., 2021</xref>). Although the B domains remain in a closed state, i.e. sitting atop the fusion machinery, in both CCoV-HuPn-2018 S conformations, the two structures differ in the tertiary and quaternary organization of the S<sub>1</sub> subunit crown. Specifically, domain A moves radially outwards upon transition from a proximal to a swung out domain 0 conformation, positioning it &gt;6Å further away from the B domain belonging to the same protomer (<xref ref-type="fig" rid="F1">Figure 1F-H</xref>). As a result, domain A moves closer to and forms tight interactions with the C domain of a neighboring protomer in the swung out domain 0 state. Overall, interactions among C domains contribute to a marked enhancement of the total surface area buried between S<sub>1</sub> protomers (stabilizing the S<sub>1</sub> trimeric trimer) whereas the B domains reduce tertiary and quaternary contacts with their surroundings, likely enabling subsequent opening and receptor engagement (cf. below).</p><p id="P7">The CCoV-HuPn-2018 S lacks a polybasic furin cleavage site at the S<sub>1</sub>/S<sub>2</sub> junction, similar to type II feline and canine coronaviruses (<xref ref-type="bibr" rid="R36">Licitra et al., 2013</xref>; <xref ref-type="bibr" rid="R47">Millet and Whittaker, 2015</xref>). Accordingly, we did not detect proteolytic processing of CCoV-HuPn-2018 S transfected in HEK293T cells, similar to HCoV-229E S (<xref ref-type="fig" rid="F1">Figure 1G</xref>). In contrast, transfection of HEK293T cells with SARS-CoV-2 S or MERS-CoV S leads to cleavage at S<sub>1</sub>/S<sub>2</sub> by furin-like proteases (<xref ref-type="fig" rid="F1">Figure 1G</xref>) (<xref ref-type="bibr" rid="R46">Millet and Whittaker, 2014</xref>, <xref ref-type="bibr" rid="R47">2015</xref>; <xref ref-type="bibr" rid="R78">Walls et al., 2020a</xref>). The CCoV-HuPn-2018 S<sub>2</sub>’ site contains a polybasic motif K<sub>953</sub>RKYR<sub>957</sub> which is identical to the one found in TGEV S and some type II feline and canine coronavirus S sequences (<xref ref-type="bibr" rid="R47">Millet and Whittaker, 2015</xref>) and might modulate cleavage and infectivity.</p></sec><sec id="S3"><title>Organization of the CCoV-HuPn-2018 S<sub>1</sub> subunit</title><p id="P8">Coronaviruses can use multiple domains within the S<sub>1</sub> subunit for receptor attachment and some coronavirus spike glycoproteins engage more than one receptor type to enter host cells (<xref ref-type="bibr" rid="R27">Hulswit et al., 2019</xref>; <xref ref-type="bibr" rid="R32">Lempp et al., 2021</xref>; <xref ref-type="bibr" rid="R33">Li et al., 2017</xref>; <xref ref-type="bibr" rid="R48">Park et al., 2019</xref>; <xref ref-type="bibr" rid="R49">Peng et al., 2011</xref>; <xref ref-type="bibr" rid="R67">Tortorici et al., 2019</xref>). Domain A folds as a galectin-like β-sandwich and most closely resembles the equivalent domains of α-coronavirus S glycoproteins including HCoV-NL63 (<xref ref-type="bibr" rid="R75">Walls et al., 2016b</xref>), HCoV-229E (<xref ref-type="bibr" rid="R35">Li et al., 2019</xref>), PEDV (<xref ref-type="bibr" rid="R29">Kirchdoerfer et al., 2021</xref>; <xref ref-type="bibr" rid="R84">Wrapp and McLellan, 2019</xref>) and FIPV (<xref ref-type="bibr" rid="R26">Hsu et al., 2020</xref>) with which it shares ~40% sequence identity. Superimposition of the CoV-HuPn-2018 S 0 and A domains underscores their conserved architecture and topology (r.m.s.d. 4.2 Å over 139 aligned Cα positions) although they share only 12.5% sequence identity (<xref ref-type="fig" rid="F2">Figure 2 A-G</xref>). These findings suggest that both domains derived from an ancestral gene duplication event, as previously described for HCoV-NL63 (<xref ref-type="bibr" rid="R75">Walls et al., 2016b</xref>), and accumulated extensive mutations leading to their very low sequence relatedness.</p><p id="P9">The CCoV-HuPn-2018 domain B structure is strikingly similar to the porcine respiratory coronavirus (PRCV) and transmissible gastroenteritis virus (TGEV) domain B structures (<xref ref-type="bibr" rid="R59">Reguera et al., 2012</xref>) with which it shares ~90% sequence identity, including key APN interacting residues (PRCV Y528/W571 corresponding to CCoV-HuPn-2018 Y543/W586) (<xref ref-type="fig" rid="F3">Figure 3A-C</xref>). Although the β-sandwich fold is also shared with HCoV-NL63, HCoV-229E and porcine delta-coronavirus, their receptor-binding loops adopt distinct conformations compared to CCoV-HuPn-2018, PRCV and TGEV (<xref ref-type="bibr" rid="R59">Reguera et al., 2012</xref>; <xref ref-type="bibr" rid="R61">Shang et al., 2018</xref>; <xref ref-type="bibr" rid="R83">Wong et al., 2017</xref>; <xref ref-type="bibr" rid="R85">Wu et al., 2009</xref>; <xref ref-type="bibr" rid="R86">Xiong et al., 2018</xref>) <bold>(<xref ref-type="supplementary-material" rid="SD1">Figure S3</xref>).</bold></p></sec><sec id="S4"><title>Aminopeptidase N is a receptor for CCoV-HuPn-2018</title><p id="P10">Based on the structural similarity between the B domain of CCoV-HuPn-2018 (<xref ref-type="fig" rid="F3">Figure 3A-C</xref>), and other alpha CoVs such as PRCV and TGEV, we evaluated the ability of the CCoV-HuPn- 2018 B domain to interact with several APN orthologs which is a receptor for both PRCV and TGEV (<xref ref-type="bibr" rid="R14">Delmas et al., 1992</xref>). Feline, canine and porcine APNs, but not human APN, recognized biotinylated CCoV-HuPn-2018 B domain immobilized at the surface of biolayer interferometry biosensors (<xref ref-type="fig" rid="F3">Figure 3D-G</xref>). The CCoV-HuPn-2018 B domain bound with higher affinity to canine APN (K<sub>D</sub>=1.0 nM) compared to feline APN (K<sub>D</sub>=27nM) and porcine APN (K<sub>D</sub>=41nM), as was the case for the TGEV B domain (<xref ref-type="fig" rid="F3">Figure 3D-K</xref>, <xref ref-type="supplementary-material" rid="SD1">Table S3</xref>). We also evaluated the ability of the CCoV-HuPn-2018 B domain to interact with several APN orthologs by pull-down assays and found that feline, canine and porcine APNs, but not human APN, recognized biotinylated CCoV-HuPn-2018 and TGEV B domain coupled to streptavidin beads <bold>(<xref ref-type="supplementary-material" rid="SD1">Figure S4A-B,D-E</xref>). Human APN interacted with the HCoV-229E B domain as observed by pull-down and BLI (<xref ref-type="supplementary-material" rid="SD1">Figure S4C-G</xref> and Table 3)</bold>. These data suggest that CCoV-HuPn-2018 can use several APN orthologs as receptors likely involving a binding mode comparable to PRCV/TGEV but distinct from HCoV-229E (<xref ref-type="bibr" rid="R59">Reguera et al., 2012</xref>; <xref ref-type="bibr" rid="R83">Wong et al., 2017</xref>).</p><p id="P11">We next assessed the ability of various APN orthologs to promote cell entry of vesicular stomatitis virus (VSV) particles pseudotyped with CCoV-HuPn-2018 S, TGEV S or HCoV-229E S. Transient transfection of feline, canine or porcine -but not human- APN, rendered HEK293T cells susceptible to CCoV-HuPn-2018 S VSV pseudovirus entry (<xref ref-type="fig" rid="F4">Figure 4A</xref>), in line with the binding data (<xref ref-type="fig" rid="F3">Figure 3D-G</xref>). Feline, canine and porcine APNs also promoted TGEV S pseudotyped virus entry into HEK293T cells (<xref ref-type="fig" rid="F4">Figure 4B</xref>) whereas HCoV-229E S-mediated entry occurred with feline or human APN but not with canine or porcine orthologs (<xref ref-type="fig" rid="F4">Figure 4C</xref>). Cotransfection of TMPRSS2 with APN did not enhance CCoV-HuPn-2018 S pseudovirus entry (<xref ref-type="fig" rid="F4">Figure 4D-F</xref>), likely reflecting the ability to employ redundant proteolytic pathways for membrane fusion to occur at the plasma membrane or the endosomal membrane, similar to HCoV-229E (<xref ref-type="bibr" rid="R4">Bertram et al., 2013</xref>). We also observed CCoV-HuPn-2018 S VSV entry in canine A72 cells (<xref ref-type="bibr" rid="R73">Vlasova et al., 2021</xref>), canine MDCK cells, and feline CRFK cells (<xref ref-type="supplementary-material" rid="SD1">Figure S5</xref>), presumably due to endogenous APN expression. Among the cell lines evaluated, feline and canine cell lines permitted TGEV S VSV entry whereas only feline CRFK cells facilitated entry of 229E S pseudovirus (<xref ref-type="supplementary-material" rid="SD1">Figure S5</xref>), in line with the data obtained with transfected APN orthologs (<xref ref-type="fig" rid="F4">Figure 4A-C</xref>). Finally, we observed concentration-dependent inhibition of CCoV-HuPn-2018 S pseudotyped virus entry using purified dimeric feline, canine or porcine APN-Fc fusions (<xref ref-type="fig" rid="F4">Figure 4G</xref>), establishing APN as a bona fide entry receptor for CCoV-HuPn-2018.</p><p id="P12">A key distinction between human APN and feline/canine/porcine APNs is the absence of an N-linked oligosaccharide at position N739 of the former orthologue due to a Thr to Arg residue substitution at position 741, which is position i+2 of a glycosylation sequon (<bold><xref ref-type="fig" rid="F4">Figure 4H</xref></bold>). Previous work showed that abrogation of this glycosylation site prevented binding of the TGEV RBD to cell-surface expressed porcine APN (<xref ref-type="bibr" rid="R59">Reguera et al., 2012</xref>; Tusell et al., 2007). The structural conservation of the CCoV-HuPn-2018 and TGEV/PRCV B domains suggest that the absence of this oligosaccharide is responsible for the lack of detectable binding and inability of CCoV-HuPn-2018 S to utilize human APN for cell entry. To evaluate this hypothesis, we generated a human</p><p id="P13">APN N739 oligosaccharide knockin mutant (by introducing the R741T substitution) and assessed its ability to mediate pseudotyped virus entry. Human R741T APN rendered HEK293T cells permissive to both CCoV-HuPn-2018 and TGEV S-mediated entry (<xref ref-type="fig" rid="F4">Figure 4A,B</xref>) and human R741T APN-Fc inhibited CCoV-HuPn-2018 S pseudovirus entry in a concentration-dependent manner (<xref ref-type="fig" rid="F4">Figure 4G</xref>), confirming the key role of this post-translational modification for receptor recognition. Moreover, the human APN oligosaccharide knockin mutant remained functional as demonstrated by its retained interactions with the HCoV-229E B domain (<xref ref-type="supplementary-material" rid="SD1">Figure S4F-G</xref>) and its ability to support 229E S-mediated entry into HEK293T cells (<xref ref-type="fig" rid="F4">Figure 4C</xref>) due to the distal location of the N739 oligosaccharide from the HCoV-229E attachment site (<xref ref-type="bibr" rid="R83">Wong et al., 2017</xref>).</p></sec><sec id="S5"><title>Antigenicity of the CCoV-HuPn-2018 S trimer</title><p id="P14">CCoV-HuPn-2018 S shares 47% amino acid sequence identity with HCoV-229E S and with HCoV-NL63 S and is therefore more distantly related to the S glycoproteins of these two endemic human-infecting α-coronaviruses than they are to each other (64% sequence identity). Mapping sequence conservation between these three viruses on the CCoV-HuPn-2018 S trimer structure shows that the S<sub>1</sub> subunit is more divergent than the S<sub>2</sub> subunit (<bold><xref ref-type="fig" rid="F5">Figure 5A-B</xref></bold>), a trend which holds true across all coronaviruses as a result of differential receptor usage and immune pressure (<xref ref-type="bibr" rid="R67">Tortorici and Veesler, 2019</xref>; <xref ref-type="bibr" rid="R78">Walls et al., 2020a</xref>).</p><p id="P15">To investigate the CCoV-HuPn-2018 cross-neutralization afforded by prior α-coronavirus exposure, we evaluated the serum neutralizing activity of human plasma obtained between 1985 and 1987 from individuals infected with HCoV-229E (<xref ref-type="bibr" rid="R17">Eguia et al., 2021</xref>). We observed that plasma inhibiting HCoV-229E S-mediated entry into cells also blocked CCoV-HuPn-2018 S pseudovirus entry, albeit with reduced potency (<bold><xref ref-type="fig" rid="F5">Figure 5C-D</xref> and <xref ref-type="supplementary-material" rid="SD1">Figure S6</xref></bold>). In contrast, TGEV S-mediated entry was little affected by any plasma tested (<bold><xref ref-type="fig" rid="F5">Figure 5E</xref> and <xref ref-type="supplementary-material" rid="SD1">Figure S6</xref></bold>). These findings suggest that α-coronavirus infection in humans elicit polyclonal antibody responses with some degree of neutralization breadth towards other coronaviruses in the same genera.</p><p id="P16">We subsequently evaluated the ability of the previously described PRCV/TGEV 1AF10 neutralizing monoclonal antibody (<xref ref-type="bibr" rid="R83">Wong et al., 2017</xref>) to cross-react with the CCoV-HuPn-2018 B domain. Biolayer interferometry measurements showed that the 1AF10 Fab fragment bound to the immobilized CCoV-HuPn-2018 B domain with an affinity of 17 nM with similar on and off rates than those observed for binding to the TGEV B domain (<xref ref-type="supplementary-material" rid="SD1">Figure S7</xref>). Moreover, the 1AF10 Fab potently inhibited CCoV-HuPn-2018 S and TGEV S pseudovirus entry into HEK293T cells transiently transfected with canine, feline, porcine and human APN N739 oligosaccharide knockin mutant (R741T) (<xref ref-type="fig" rid="F5">Figure 5F-G</xref>). We also demonstrated that 1AF10 inhibits APN binding competitively to both the CCoV-HuPn-2018 and the TGEV B domains indicating that this mAb prevents viral attachment to the host cell surface and would be a suitable therapeutic candidate against CCoV-HuPn-2018 (<xref ref-type="fig" rid="F5">Figure 5H-I</xref>).</p></sec></sec><sec id="S6" sec-type="discussion"><title>Discussion</title><p id="P17">Since several other α-coronaviruses interacts with cell surface carbohydrates (<xref ref-type="bibr" rid="R30">Krempl et al., 1997</xref>; <xref ref-type="bibr" rid="R45">Milewska et al., 2014</xref>; <xref ref-type="bibr" rid="R57">Regan and Whittaker, 2008</xref>; <xref ref-type="bibr" rid="R58">Regan et al., 2010</xref>), we suggest that the two snapshots we captured using cryoEM correspond to two functionally distinct conformations at various stages of the entry process. These structural changes would couple domain 0 adsorption to host cell surface glycans (putative attachment receptors) to subsequent exposure of the B domain to interact with the APN entry receptor. Subsequent protease-mediated cleavage at the S<sub>2</sub>’ site activates the spike for membrane fusion and enables initiation of infection. As similar conformational changes were detected for PEDV S which also bind glycans using domain 0 (<xref ref-type="bibr" rid="R29">Kirchdoerfer et al., 2021</xref>; <xref ref-type="bibr" rid="R84">Wrapp and McLellan, 2019</xref>), we propose that this cascade of conformational changes might be conserved among several α-coronaviruses.</p><p id="P18">We previously described that NL63 S domain A N358 glycan participates in obstructing the B domain receptor-binding loops from the same protomer as a putative immune evasion strategy (<xref ref-type="bibr" rid="R75">Walls et al., 2016b</xref>) (<xref ref-type="supplementary-material" rid="SD1">Figure S8A</xref>). The CCoV-HuPn-2018 S domain A glycan at position N404 and the domain B glycan at position N561 respectively shield the receptor-binding loops from the same and from a neighboring B domain (to a different extent in the domain 0 proximal and swung out conformations) (<xref ref-type="supplementary-material" rid="SD1">Figure S8C-D</xref>), and both might therefore play a similar role for this virus. Both CCoV-HuPn-2018 S and HCoV-NL63 S therefore appear to utilize conformational masking and glycan shielding to limit exposure of the receptor-binding loops and possibly reduce recognition by neutralizing antibodies (<xref ref-type="bibr" rid="R59">Reguera et al., 2012</xref>; <xref ref-type="bibr" rid="R75">Walls et al., 2016b</xref>; <xref ref-type="bibr" rid="R83">Wong et al., 2017</xref>).</p><p id="P19">The ongoing SARS-CoV-2 genetic drift has led to the emergence of variants harboring numerous mutations, especially in the N-terminal domain (domain A) and the receptor-binding domain (domain B) (<xref ref-type="bibr" rid="R10">Collier et al., 2021</xref>; <xref ref-type="bibr" rid="R13">Davies et al., 2021</xref>; <xref ref-type="bibr" rid="R15">Deng et al., 2021</xref>; <xref ref-type="bibr" rid="R19">Faria et al., 2021</xref>; <xref ref-type="bibr" rid="R39">McCallum et al., 2021a</xref>, <xref ref-type="bibr" rid="R40">2021b</xref>; <xref ref-type="bibr" rid="R64">Tegally et al., 2021</xref>; <xref ref-type="bibr" rid="R66">Thomson et al., 2021</xref>). Many of these variants exhibit altered transmissibility, immune evasion, replication kinetics or disease severity relative to the ancestral SARS-CoV-2 isolate (<xref ref-type="bibr" rid="R7">Cele et al., 2021</xref>; <xref ref-type="bibr" rid="R10">Collier et al., 2021</xref>; <xref ref-type="bibr" rid="R13">Davies et al., 2021</xref>; <xref ref-type="bibr" rid="R16">Edara et al., 2021</xref>; <xref ref-type="bibr" rid="R37">Liu et al., 2021a</xref>, <xref ref-type="bibr" rid="R38">2021b</xref>; <xref ref-type="bibr" rid="R39">McCallum et al., 2021a</xref>, <xref ref-type="bibr" rid="R40">2021b</xref>; <xref ref-type="bibr" rid="R53">Plante et al., 2020</xref>; <xref ref-type="bibr" rid="R82">Wibmer et al., 2021</xref>). Similarly, a longitudinal survey of HCoV-229E isolates revealed that the (B domain) receptor-binding loops evolve rapidly relative to the rest of the genome resulting in changes in receptor-binding affinity and antigenicity (<xref ref-type="bibr" rid="R83">Wong et al., 2017</xref>). This antigenic drift results in dampened serum neutralization titers of HCoV-229E isolates that have emerged several years after infection (<xref ref-type="bibr" rid="R17">Eguia et al., 2021</xref>). Nevertheless, the existence in HCoV-229E patient sera of some cross-reactive Abs with detectable neutralizing activity against CCoV-HuPn-2018 has the potential to reduce disease severity of this virus in humans.</p><p id="P20">Single nucleotide polymorphisms of the APN gene (<italic>ANPEP</italic>) have been previously described in humans (<xref ref-type="bibr" rid="R72">Vijgen et al., 2004</xref>) and pigs (<xref ref-type="bibr" rid="R6">Bovo et al., 2021</xref>) and we identified a rare R741G-carrying allele in a heterozygous individual in public databases (cf. methods), which does not, however, introduce a glycosylation sequon. Moreover, we observed a near-perfect sequence conservation of the CCoV-HuPn-2018 receptor-binding loops with those of TGEV/PRCV although they are distinct viruses. Collectively, these data along with the failure of CCoV-HuPn-2018 S to utilize wildtype human APN and its isolation using canine A72 cells (<xref ref-type="bibr" rid="R73">Vlasova et al., 2021</xref>), suggest that CCoV-HuPn-2018 is not well adapted for infection and replication in human hosts. These findings also suggest that patients infected with this novel virus or with related canine and feline coronaviruses (<xref ref-type="bibr" rid="R62">Silva and Mullis, 2014</xref>; <xref ref-type="bibr" rid="R73">Vlasova et al., 2021</xref>) might harbor <italic>ANPEP</italic> variants introducing an oligosaccharide at position N739 which we have shown to be necessary and sufficient to support CCoV-HuPn-2018 S-mediated entry. The rarity of these single nucleotide polymorphisms is expected to restrict the zoonotic potential of CCoV-HuPn-2018 to a small number of individuals in the absence of further viral adaptations.</p><p id="P21">The detection of viruses genetically related to canine and feline coronaviruses, including CCoV-HuPn-2018, in humans across two different continents revealed that cross-species transmission of α-coronavirus-1 species, which were not previously known to infect humans, might occur recurrently (<xref ref-type="bibr" rid="R62">Silva and Mullis, 2014</xref>; <xref ref-type="bibr" rid="R73">Vlasova et al., 2021</xref>; <xref ref-type="bibr" rid="R87">Xiu et al., 2020</xref>). Moreover, demonstration of the ability of porcine deltacoronavirus to use human APN for cell entry and identification of multiple zoonotic transmission events in children in Haiti add an additional coronavirus to the growing list of emerging human pathogens (<xref ref-type="bibr" rid="R31">Lednicky et al., 2021</xref>; <xref ref-type="bibr" rid="R34">Li et al., 2018</xref>). The data presented here along with continued surveillance and characterization of emerging coronaviruses will support pandemic preparedness efforts similar to prior work that enabled a rapid response to the COVID-19 pandemic.</p></sec><sec id="S7" sec-type="methods"><title>Methods</title><sec id="S8"><title>Cell lines</title><p id="P22">Cell lines used in this study were obtained from ATCC: Human cells epithelial embryo (HEK293T, CRL-3216), <italic>Felis catus</italic> (CRFK, CCL-94), <italic>Canis familiaris</italic> epithelial kidney cells (MDCK, CCL-34), <italic>Canis familiaris</italic> tumor fibroblast cells (A-72, CRL-1542) and <italic>Sus scrofa</italic> pig testis fibroblast cells (ST, CRL-1746) or ThermoFisher Scientific: ExpiCHO cells and Expi293F™ cells. Cells were cultivated at 37°C, in an atmosphere of 5 % CO<sub>2</sub> and with 130 rpm of agitation for suspension cells. None of the cell lines used were routinely tested for mycoplasma contamination.</p></sec><sec id="S9"><title>Plasmids</title><p id="P23">Genes used in this study were synthesized by GenScript, codon optimized for expression in mammalian cells, cloned into pcDNA3.1 (+) between KpnI and XhoI, in frame with a Kozak’s sequence to direct translation and with the signal peptide derived from the μ phosphatase: MGILPSPGMPALLSLVSLLSVLLMGCVAETGT (except for the full-length genes in which the original signal peptide was used). CCoV-HuPn-2018-S-2P corresponds to the sequence with the entry code: QVL91811.1 and includes residues 17 to 1387. To stabilize the spike in prefusion conformation, residues L (1140) and E (1141) were mutated to 2 P. Full-length wild-type S glycoproteins from HCoV-229E (AAK32191.1) residues: 1-1,155, CCoV-HuPn-2018 (QVL91811.1) residues 1-1,425 and TGEV (ABG89335.1) residues: 1-1,425, harbor C-terminal deletions of 18-, 23- and 23-residues, respectively, were used to pseudotype VSVΔG-luc. HCoV-229E, CCoV-HuPn-2018 and TGEV RBDs matching with the full-length sequences indicated above, include residues: 293 to 434, 539 to 671 and 522 to 665, respectively. Full-length APNs from human (NP_001141.2), feline (NP_001009252.2), canine (NP_001139506.1) and pig (AGX93258.1) orthologs comprise residues: 1-967, 1-967, 1-975 and 1-963, respectively. APNs wild-type ectodomains orthologs from human, feline, canine, pig, and human mutated (NWT) from the same sequence codes shown above, comprise residues: 66 to 967, 64 to 967, 71 to 975 and 62 to 963, respectively. The 1AF10 Fab light and heavy sequences were obtained from <xref ref-type="bibr" rid="R59">Reguera et al., 2012</xref> and cloned separately into pcDNA3.1. Only the heavy chain was fused C-terminally with an 8 residues his-tag through a GGSGGS linker.</p></sec><sec id="S10"><title>Mutagenesis</title><p id="P24">Full-length wild-type human APN encoding plasmid was used as a template to create a glycosilation sequence at position N739 (NW<underline>R</underline> to NW<underline>T</underline> change) in a reaction mixture containing: 2X Kapa HiFi (Kapa biosystems) and the following primers, each at 10 μM: 5’-aataccaacaactgg<underline>acc</underline>gagatcc-3’ (underline is the codon change R to T) and 5’-atttctgaagtgaatgaagagg-3’ from Integrated DNA Technologies (IDT). The introduction of the desired mutation R to T was verified by sequencing purified plasmids by GENEWIZ. The plasmid harboring the mutation was further amplified and purified with EndoFree maxi kit (Qiagen) to be suitable for transfection into mammalian cells.</p></sec><sec id="S11"><title>Protein expression and purification</title><p id="P25">200 ml of ExpiCHO-S cells grown to a density of 6 x 10<sup>6</sup>/mL, were transfected with 640 μl of Expifectamine CHO reagent (ThermoFisher) and 200 μg of CCoV-HuPn-2018-S-2P following manufacturer’s recommendations. The day after transfection, feed and enhancer were added to the cells. Six days post-transfection, supernatants were clarified by centrifugation at 800 g for 10 minutes. Followed addition of 20 mM imidazole, 300 mM NaCl and 20 mM Tris-HCl pH 8.0, supernatants were further centrifuged at 14,000 g for 30 min and passed through a 1 mL His trap HP column (Cytiva) previously equilibrated with binding buffer (25 mM Tris pH 7.4 and 350 mM NaCl). CCoV-HuPn-2018-S-2P was eluted using a linear gradient of 500 mM imidazole.</p><p id="P26">To express B domains from CCoV-HuPn-2018, TGEV and HCoV-229E fused to an avidin and a histidine tag, 100 ml of Expi293F cells at 3 x 10<sup>6</sup>/mL were transiently transfected with 320 μl of Expifectamine and 100 μg of the respective plasmids, following the manufacturer’s indications. Four days post-transfection, supernatants were clarified by centrifugation at 800 g for 10 minutes, supplemented with 20 mM imidazole, 300 mM NaCl and 25 mM Tris-HCl pH 8.0, further centrifuged at 14,000 g for 30 min and passed through a 1 mL His trap HP column (Cytiva) previously equilibrated with binding buffer (25mM Tris pH 7.4 and 350mM NaCl). B domains were eluted using a linear gradient of 500 mM imidazole. Similar protocol was used to express and purify the Fab 1AF10 fused to 8 residues histidine tag except that 50 ml of Expi293F cells were transfected with a mixture containing: 50 μg of the individual plasmidsA encoding the light chain and heavy chain of the Fab and 160 μl of Expifectamine.</p><p id="P27">To express APN ectodomains from human, feline, canine and pig orthologs fused to Fc portion of human IgG, Expi293F cells were transiently transfected with the respective plasmids following the manufacturer’s protocols. Briefly, 50 ml of Expi293F cells at 3 x 10<sup>6</sup>/mL were transfected using 160 μl of Expifectamine and 50 μg of APN plasmid. Four days after transfection, supernatants were clarified by centrifugation at 800 g for 10 minutes, supplemented with 300 mM NaCl and 25 mM Tris-HCl pH 8.0, further centrifuged at 14,000 g for 30 min and passed through a 1 mL HiTrap Protein A HP column (Cytiva). Proteins were eluted using 0.1 M citric acid pH 3.0 in individual tubes containing 200 μl of 1 M Tris-HCl pH 9.0 to immediately neutralize the low pH needed for elution. Fractions containing the proteins were pooled and buffer exchanged to 25 mM Tris-HCl pH 8.0, 150 mM NaCl. To produce monomeric APNs, the Fc tag of all APN orthologs was removed using thrombin (Millipore Sigma) in a reaction mixture containing: 3 μg of thrombin/mg of APN-Fc, 20 mM Tris-HCl pH 8.0, 150 mM NaCl and 2.5 mM CaCl<sub>2</sub> incubated overnight at room temperature. The reaction mixture was then loaded to a Protein A column to separate from uncleaved APN-Fc and the Fc tag. Monomeric APNs were further purified by size-exclusion chromatography (SEC) on a Superdex 200 column 10/300 GL (GE Life Sciences) previously equilibrated in 25 mM Tris pH 8.0 and 150 mM NaCl.</p></sec><sec id="S12"><title>Protein Biotinylation</title><p id="P28">B domains from HCoV-229E, TGEV and CCoV-HuPn-2018 were biotinylated using BirA biotin-protein ligase standard reaction kit (Avidity) following manufacturer’s protocol. In a typical reaction, 40μM of B domains were incubated overnight at 4°C with 2.5 μg of BirA enzyme in reaction mixtures containing 1X BiomixB, 1X BiomixA and 40 μM BIO200. Domains B were further purified by SEC using Superdex 75 increase 10/300 GL (GE LifeSciences) and concentrated using 10 kDa filters (Amicon).</p></sec><sec id="S13"><title>Biolayer interferometry</title><p id="P29">APNs binding measurements to B domains were performed using Biolayer interferometry. Biotinylated B domains from CCoV-HuPn-2018, TGEV and HCoV-229E were immobilized to strep-avidin (SA) biosensors, at 1 μg/mL in undiluted 10X kinetics buffer (Pall) to SA sensors that were pre-hydrated in water for at least 10 minutes and then equilibrated into 10X Kinetics Buffer (Pall). The RBDs were loaded to a level of 1 nm total shift. The loaded tips were then dipped into a dilution series of monomeric APN orthologs from human, feline, canine, and porcine or 1AF10 Fab in 10X Kinetics Buffer (Pall) starting at various concentrations for 300 seconds prior to 300 seconds dissociation in 10X Kinetics buffer for kinetics determination. The data were baseline subtracted and the plots fitted using the Pall FortéBio/Sartorius analysis software (v.12.0). Data were plotted in Graphpad Prism (v.9.0.2). These experiments were done side-by-side with two different batches of B domains and APN orthologs preparations. Competition BLI used 10X protein above measured K<sub>D</sub> (for example, for CCOV-HuPn-2018 170nM of 1AF10 fab was used with a K<sub>D</sub> of 17nM). CCoV-HuPn-2018 or TGEV biotinylated RBD was immobilized at 1 μg/mL in undiluted 10X kinetics buffer (Pall) to SA sensors that were prehydrated in water for at least 10 minutes and then equilibrated into 10X Kinetics Buffer (Pall). The RBDs were loaded to a level of 1 nm total shift. The loaded tips were then dipped first into 10X above K<sub>D</sub> of 1AF10 fab diluted in 10X kinetics buffer, then into 1AF10 fab alone or 1AF10 fab plus 10X above K<sub>D</sub> of with canine, feline, or porcine APN (Table 1). The data were baseline subtracted and fit using the Pall FortéBio/Sartorius analysis software (v.12.0). Data were plotted in Graphpad Prism (v.9.0.2).</p></sec><sec id="S14"><title>Pull-down assay</title><p id="P30">The interaction between APN orthologs and B domains was further analyzed performing a pull-down assay. Briefly, 200 μl (2mg) of magnetic beads Dynabeads™ Strep Isolation (ThermoFisher) were washed twice with 300 μL 1X TBS-T (2.4 g Tris-Base, 8 g NaCl, 0.1 % Tween20) using a magnetic stand (ThermoFisher) before coupling them with 200 μl of B domains in TBS at 0.125 ng/ml. The mixture beads/protein were well mixed and incubator at room temperature with constant gentle rotation. After 1 h incubation, beads were washed two times with 200 μL TBS-T before resuspending in a solution containing an excess of 10-20X of their calculated K<sub>D</sub> using BLI, of the APN-Fc orthologs and allow binding for 1 hr at RT with gently rotation after which were washed two times with TBS-T. Flow through, last wash and beads were collected and analyzed in SDS-PAGE gel. Control assays consisted of uncoupled beads–APN- Fc.</p></sec><sec id="S15"><title>VSV-based pseudotyped virus production</title><p id="P31">CCoV-HuPn, HCoV-229E (AAK32191.1, P100E isolate) and TGEV S pseudotyped vesicular stomatitis virus (VSV), were generated as previously described (<xref ref-type="bibr" rid="R69">Tortorici et al., 2020</xref>, <xref ref-type="bibr" rid="R70">2021</xref>). Briefly, HEK293T cells in DMEM supplemented with 19% FBS and 1% PenStrep and seeded in poly-D-lysine coated 10-cm dishes were transfected with a mixture of 24 μg of the corresponding plasmid encoding for: CCoV-HuPn S, TGEV S or HCoV-229 S, 60 μl Lipofectamine 2000 (Life Technologies) in 3 ml of Opti-MEM, following manufacturer’s instructions. After 5 h at 37°C, DMEM supplemented with 20% FBS and 2% PenStrep was added. Next day, cells were washed three times with DMEM and were transduced with VSVΔG-luc (Kaname et al., 2010). After 2 h, virus inoculum was removed and cells were washed five times with DMEM prior addition of DMEM supplemented with anti-VSV-G antibody [Il-mouse hybridoma supernatant diluted 1 to 25 (v/v), from CRL-2700, ATCC] to minimize parental background. After 18-24 h, supernatants containing pseudotyped VSVs were harvested, centrifuged at 2,000 x g for 5 minutes to remove cellular debris, filtered with a 0,45 μm membrane, concentrated 10 times using a 30 kDa cut off membrane (Amicon), aliquoted, and frozen at -80°C.</p></sec><sec id="S16"><title>Pseudotyped virus infections and neutralizations</title><p id="P32">For pseudotyped VSV infections and neutralizations, HEK293T cells were transfected with plasmids encoding for the different full-length APN orthologs (flAPN) following the protocol described by (<xref ref-type="bibr" rid="R17">Eguia et al., 2021</xref>). Briefly, HEK293T cells at 90% confluency and seeded in poly-D-lysine coated 10-cm dishes were transfected with a mixture in Opti-MEM containing 8 μg of the corresponding plasmid encoding flAPN orthologs, 1 μg of the plasmid encoding full-length TMPRSS2 and 30 μl of Lipofectamine 2000 (Life Technologies) according to manufacturer’s instructions. After 5 h at 37°C, cells were trypsinized, seeded into poly-D-lysine coated clear bottom white walled 96-well plates at 40,000-50,000 cells/well and cultured overnight at 37°C. For infections, 20 μl of the corresponding pseudotyped VSV were mixed with 20 μl of DMEM and the mixture was added to the cells previously washed three times with DMEM. After 2 h at 37°C, 40 μl of DMEM was added and cells were further incubated ON at 37°C. For neutralizations, eleven 2-fold serial dilutions of Fab1AF10, APN ectodomains orthologs or sera, were prepared in DMEM. 20 μl of CCoV-HuPn-2018 S, HCoV-229E S or TGEV S pseudotyped VSV were added 1:1 (v/v) to each Fab1AF10, APN ectodomains or sera dilution and mixtures were incubated for 45-60 min at 37°C. After removing their media, transfected HEK293T cells were washed three times with DMEM and 40 μL of the mixture containing virus:Fab/APN ectodomains/sera were added. One hour later, 40 μL DMEM were added to the cells. After 17-20 h, 60 μL of One-Glo-EX substrate (Promega) were added to each well and incubated on a plate shaker in the dark. After 5-15 min incubation, plates were read on a Biotek plate reader. Measurements were done in duplicate with biological replicates. Relative luciferase units were plotted and normalized in Prism (GraphPad): cells alone without pseudovirus was defined as 0 % infection, and cells with virus only (no sera) was defined as 100 % infection. Most of the human sera was collected from prospective bone marrow donors in Seattle with approval from the Human Subjects Institutional Review Board in the 1980s and were stored in the Infectious Disease Sciences Biospecimen Repository at the Vaccine and Infectious Disease Division of the Fred Hutch Cancer Center. A few of the sera (the ones prefixed “FH”) are residual samples from Bloodworks Northwest that were collected from adults in Seattle.</p></sec><sec id="S17"><title>Western Blot</title><p id="P33">15 μl of pseudotyped VSV were mix with 4X SDS-PAGE loading buffer, run on a 4%–15% gradient Tris-Glycine Gel (BioRad) and transferred to PVDF membrane using the protocol mix molecular weight of the Trans-Blot Turbo System (BioRad). Membrane was blocked with 5% milk in TBS-T (20 mM Tris-HCl pH 8.0, 150 mM NaCL) supplemented with 0.05% Tween-20 at room temperature and with agitation. After 1 h, the fusion-peptide-specific S2S8 monoclonal antibody was added at 1:250 dilution and incubated ON at 4°C with agitation. Next day, the membrane was washed three times with TBS-T and an Alexa Fluor 680-conjugated goat anti-human secondary antibody (1:50,000 dilution, Jackson ImmunoResearch, 109-625-098) was added and incubated during 1 h at room temperature. Membrane was washed three times with TBS-T after which a LI-COR processor was used to develop the western blot.</p></sec><sec id="S18"><title>CryoEM sample preparation, data collection and data processing</title><p id="P34">Three microliters of recombinantly expressed and purified CCoV-HuPn-2018 at approximately 0.3 mg/ml were three times loaded onto freshly glow lacey grids covered with a thin layer of manually prior to plunge freezing using a vitrobot MarkIV (ThermoFisher Scientific) with a blot force of -1 and 2.5 sec blot time at 100% humidity and 21 °C. Data were acquired using the Leginon software (<xref ref-type="bibr" rid="R63">Suloway et al., 2005</xref>) to control a FEI Titan Krios transmission electron microscope equipped with a Gatan K3 direct detector and operated at 300 kV with a Gatan Quantum GIF energy filter. The dose rate was adjusted to 3.75 counts/super- resolution pixel/s, and each movie was acquired in 75 frames of 40 ms with a pixel size of 0.843 Å and a defocus range comprised between –0.8 and –2.0 μm. Movie frame alignment, estimation of the microscope contrast-transfer function parameters, particle picking and extraction (with a sampled pixel size of 1.686 Å and box size of 320 pixels<sup>2</sup>) were carried out using Warp (<xref ref-type="bibr" rid="R65">Tegunov and Cramer, 2019</xref>). Two rounds of reference-free 2D classification were performed using cryoSPARC (<xref ref-type="bibr" rid="R55">Punjani et al., 2017</xref>) to select well-defined particle images. Subsequently, one round of 3D classification with 50 iterations, using ab initio as a reference model (angular sampling 7.5 ° for 25 iterations and 1.8 ° with local search for 25 iterations) was carried out using Relion (<xref ref-type="bibr" rid="R89">Zivanov et al., 2018</xref>) without imposing symmetry. 3D refinements were carried out using non-uniform refinement in cryoSPARC (<xref ref-type="bibr" rid="R56">Punjani et al., 2020</xref>). Particle images were subjected to Bayesian polishing (<xref ref-type="bibr" rid="R90">Zivanov et al., 2019</xref>) using Relion during which particles were re-extracted with a box size of 512 pixels at a pixel size of 0.843 Å which was followed by another round of non-uniform refinement in cryoSPARC followed by per-particle defocus refinement and again non-uniform refinement. To improve the density of the domain 0, particles were symmetry-expanded and subjected to a Relion focus 3D classification without refining angles and shifts using a soft mask encompassing domain 0. Local resolution estimation, filtering, and sharpening were carried out using CryoSPARC. Reported resolutions are based on the gold-standard Fourier shell correlation (FSC) of 0.143 criterion (<xref ref-type="bibr" rid="R60">Rosenthal and Henderson, 2003</xref>) and Fourier shell correlation curves were corrected for the effects of soft masking by high- resolution noise substitution (<xref ref-type="bibr" rid="R8">Chen et al., 2013</xref>).</p></sec><sec id="S19"><title>CryoEM model building and analysis</title><p id="P35">UCSF Chimera (<xref ref-type="bibr" rid="R50">Pettersen et al., 2004</xref>) and Coot (<xref ref-type="bibr" rid="R18">Emsley et al., 2010</xref>) were used to fit atomic models (PDB 5SZS) into the cryoEM maps and Domain 0 was manually built. Models were refined and rebuilt into the maps using Coot and Rosetta (<xref ref-type="bibr" rid="R20">Frenz et al., 2019</xref>; <xref ref-type="bibr" rid="R81">Wang et al., 2016</xref>). Model validation was done using (<xref ref-type="bibr" rid="R9">Chen et al., 2010</xref>) and Privateer (<xref ref-type="bibr" rid="R1">Agirre et al., 2015</xref>). Figures were generated using UCSF ChimeraX (Goddard et al., 2018). Topology diagrams were generated using the program TopDraw (<xref ref-type="bibr" rid="R5">Bond, 2003</xref>).</p></sec><sec id="S20"><title>Assessment of human <italic>ANPEP</italic> diversity.</title><p id="P36">We assessed human diversity at or near the NWT motif (NWR in human; R741) in Gnomad (<ext-link ext-link-type="uri" xlink:href="https://gnomad.broadinstitute.org/gene/ENSG00000166825">https://gnomad.broadinstitute.org/gene/ENSG00000166825</ext-link>). Observations in approximately 125,000 humans included one heterozygous N738K, one heterozygous R741G and one heterozygous I743N. No rare defects in <italic>ANPEP</italic> are described in OMIM (<ext-link ext-link-type="uri" xlink:href="https://www.omim.org/entry/151530">https://www.omim.org/entry/151530</ext-link>)</p></sec></sec><sec sec-type="supplementary-material" id="SM"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="SD1"><label>Supplementary Material</label><media xlink:href="EMS162965-supplement-Supplementary_Material.pdf" mimetype="application" mime-subtype="pdf" id="d55aAdDbB" position="anchor"/></supplementary-material></sec></body><back><ack id="S21"><title>Acknowledgements</title><p>We thank Hideki Tani (University of Toyama) for providing the reagents necessary for preparing VSV pseudotyped viruses. This study was supported by the National Institute of Allergy and Infectious Diseases (DP1AI158186 and HHSN272201700059C to D.V.), the National Institute of General Medical Sciences (R01GM120553 to D.V.), a Pew Biomedical Scholars Award (D.V.), an Investigators in the Pathogenesis of Infectious Disease Awards from the Burroughs Wellcome Fund (D.V.), Fast Grants (D.V.) and the Bill &amp; Melinda Gates Foundation (OPP1156262 to D.V.), the University of Washington Arnold and Mabel Beckman cryoEM center and the National Institute of Health grant S10OD032290 (to D.V.).</p></ack><fn-group><fn id="FN1" fn-type="con"><p id="P37"><bold>Author contributions</bold></p><p id="P38">M.A.T. and D.V. conceived the project. M.A.T., A.C.W and D.V. designed experiments. A.C.W. and A.J. performed BLI binding assays. M.A.T. and A.J. carried out pull-down assays. M.A.T. ran pseudotyped virus entry assays. M.A.T. and A.J. expressed and purified the recombinant proteins. M.A.T. and Y.J.P. collected the cryoEM data. M.A.T. processed the cryoEM data. M.A.T. and D.V. built and refined the atomic models. A.T. performed the SNP analysis. R.T.E., T.S.A., M.J.B. A.L., D.C. and J.B. provided unique reagents. M.A.T. and D.V. wrote the manuscript with input from all authors.</p></fn></fn-group><ref-list><ref id="R1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Agirre</surname><given-names>J</given-names></name><name><surname>Iglesias-Fernández</surname><given-names>J</given-names></name><name><surname>Rovira</surname><given-names>C</given-names></name><name><surname>Davies</surname><given-names>GJ</given-names></name><name><surname>Wilson</surname><given-names>KS</given-names></name><name><surname>Cowtan</surname><given-names>KD</given-names></name></person-group><article-title>Privateer: software for the conformational validation of carbohydrate structures</article-title><source>Nat Struct Mol Biol</source><year>2015</year><volume>22</volume><fpage>833</fpage><lpage>834</lpage><pub-id pub-id-type="pmid">26581513</pub-id></element-citation></ref><ref id="R2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anthony</surname><given-names>SJ</given-names></name><name><surname>Gilardi</surname><given-names>K</given-names></name><name><surname>Menachery</surname><given-names>VD</given-names></name><name><surname>Goldstein</surname><given-names>T</given-names></name><name><surname>Ssebide</surname><given-names>B</given-names></name><name><surname>Mbabazi</surname><given-names>R</given-names></name><name><surname>Navarrete-Macias</surname><given-names>I</given-names></name><name><surname>Liang</surname><given-names>E</given-names></name><name><surname>Wells</surname><given-names>H</given-names></name><name><surname>Hicks</surname><given-names>A</given-names></name><etal/></person-group><article-title>Further Evidence for Bats as the Evolutionary Source of Middle East Respiratory Syndrome Coronavirus</article-title><source>MBio</source><year>2017</year><volume>8</volume><pub-id pub-id-type="pmcid">PMC5380844</pub-id><pub-id pub-id-type="pmid">28377531</pub-id><pub-id pub-id-type="doi">10.1128/mBio.00373-17</pub-id></element-citation></ref><ref id="R3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baum</surname><given-names>A</given-names></name><name><surname>Fulton</surname><given-names>BO</given-names></name><name><surname>Wloga</surname><given-names>E</given-names></name><name><surname>Copin</surname><given-names>R</given-names></name><name><surname>Pascal</surname><given-names>KE</given-names></name><name><surname>Russo</surname><given-names>V</given-names></name><name><surname>Giordano</surname><given-names>S</given-names></name><name><surname>Lanza</surname><given-names>K</given-names></name><name><surname>Negron</surname><given-names>N</given-names></name><name><surname>Ni</surname><given-names>M</given-names></name><etal/></person-group><article-title>Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies</article-title><source>Science</source><year>2020</year><pub-id pub-id-type="pmcid">PMC7299283</pub-id><pub-id pub-id-type="pmid">32540904</pub-id><pub-id pub-id-type="doi">10.1126/science.abd0831</pub-id></element-citation></ref><ref id="R4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bertram</surname><given-names>S</given-names></name><name><surname>Dijkman</surname><given-names>R</given-names></name><name><surname>Habjan</surname><given-names>M</given-names></name><name><surname>Heurich</surname><given-names>A</given-names></name><name><surname>Gierer</surname><given-names>S</given-names></name><name><surname>Glowacka</surname><given-names>I</given-names></name><name><surname>Welsch</surname><given-names>K</given-names></name><name><surname>Winkler</surname><given-names>M</given-names></name><name><surname>Schneider</surname><given-names>H</given-names></name><name><surname>Hofmann-Winkler</surname><given-names>H</given-names></name><etal/></person-group><article-title>TMPRSS2 activates the human coronavirus 229E for cathepsin-independent host cell entry and is expressed in viral target cells in the respiratory epithelium</article-title><source>J Virol</source><year>2013</year><volume>87</volume><fpage>6150</fpage><lpage>6160</lpage><pub-id pub-id-type="pmcid">PMC3648130</pub-id><pub-id pub-id-type="pmid">23536651</pub-id><pub-id pub-id-type="doi">10.1128/JVI.03372-12</pub-id></element-citation></ref><ref id="R5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bond</surname><given-names>CS</given-names></name></person-group><article-title>TopDraw: a sketchpad for protein structure topology cartoons</article-title><source>Bioinformatics</source><year>2003</year><volume>19</volume><fpage>311</fpage><lpage>312</lpage><pub-id pub-id-type="pmid">12538265</pub-id></element-citation></ref><ref id="R6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bovo</surname><given-names>S</given-names></name><name><surname>Schiavo</surname><given-names>G</given-names></name><name><surname>Ribani</surname><given-names>A</given-names></name><name><surname>Utzeri</surname><given-names>VJ</given-names></name><name><surname>Taurisano</surname><given-names>V</given-names></name><name><surname>Ballan</surname><given-names>M</given-names></name><name><surname>Muñoz</surname><given-names>M</given-names></name><name><surname>Alves</surname><given-names>E</given-names></name><name><surname>Araujo</surname><given-names>JP</given-names></name><name><surname>Bozzi</surname><given-names>R</given-names></name><etal/></person-group><article-title>Describing variability in pig genes involved in coronavirus infections for a One Health perspective in conservation of animal genetic resources</article-title><source>Scientific Reports</source><year>2021</year><volume>11</volume><pub-id pub-id-type="pmcid">PMC7873263</pub-id><pub-id pub-id-type="pmid">33564056</pub-id><pub-id pub-id-type="doi">10.1038/s41598-021-82956-0</pub-id></element-citation></ref><ref id="R7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cele</surname><given-names>S</given-names></name><name><surname>Gazy</surname><given-names>I</given-names></name><name><surname>Jackson</surname><given-names>L</given-names></name><name><surname>Hwa</surname><given-names>S-H</given-names></name><name><surname>Tegally</surname><given-names>H</given-names></name><name><surname>Lustig</surname><given-names>G</given-names></name><name><surname>Giandhari</surname><given-names>J</given-names></name><name><surname>Pillay</surname><given-names>S</given-names></name><name><surname>Wilkinson</surname><given-names>E</given-names></name><name><surname>Naidoo</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Escape of SARS-CoV-2 501Y.V2 from neutralization by convalescent plasma</article-title><source>Nature</source><year>2021</year><pub-id pub-id-type="pmcid">PMC9867906</pub-id><pub-id pub-id-type="pmid">33780970</pub-id><pub-id pub-id-type="doi">10.1038/s41586-021-03471-w</pub-id></element-citation></ref><ref id="R8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>S</given-names></name><name><surname>McMullan</surname><given-names>G</given-names></name><name><surname>Faruqi</surname><given-names>AR</given-names></name><name><surname>Murshudov</surname><given-names>GN</given-names></name><name><surname>Short</surname><given-names>JM</given-names></name><name><surname>Scheres</surname><given-names>SH</given-names></name><name><surname>Henderson</surname><given-names>R</given-names></name></person-group><article-title>High-resolution noise substitution to measure overfitting and validate resolution in 3D structure determination by single particle electron cryomicroscopy</article-title><source>Ultramicroscopy</source><year>2013</year><volume>135</volume><fpage>24</fpage><lpage>35</lpage><pub-id pub-id-type="pmcid">PMC3834153</pub-id><pub-id pub-id-type="pmid">23872039</pub-id><pub-id pub-id-type="doi">10.1016/j.ultramic.2013.06.004</pub-id></element-citation></ref><ref id="R9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>VB</given-names></name><name><surname>Arendall</surname><given-names>WB</given-names></name><name><surname>Headd</surname><given-names>JJ</given-names></name><name><surname>Keedy</surname><given-names>DA</given-names></name><name><surname>Immormino</surname><given-names>RM</given-names></name><name><surname>Kapral</surname><given-names>GJ</given-names></name><name><surname>Murray</surname><given-names>LW</given-names></name><name><surname>Richardson</surname><given-names>JS</given-names></name><name><surname>Richardson</surname><given-names>DC</given-names></name></person-group><article-title>MolProbity: all-atom structure validation for macromolecular crystallography</article-title><source>Acta Crystallogr D Biol Crystallogr</source><year>2010</year><volume>66</volume><fpage>12</fpage><lpage>21</lpage><pub-id pub-id-type="pmcid">PMC2803126</pub-id><pub-id pub-id-type="pmid">20057044</pub-id><pub-id pub-id-type="doi">10.1107/S0907444909042073</pub-id></element-citation></ref><ref id="R10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Collier</surname><given-names>DA</given-names></name><name><surname>De Marco</surname><given-names>A</given-names></name><name><surname>Ferreira</surname><given-names>IATM</given-names></name><name><surname>Meng</surname><given-names>B</given-names></name><name><surname>Datir</surname><given-names>R</given-names></name><name><surname>Walls</surname><given-names>AC</given-names></name><name><surname>Kemp S</surname><given-names>SA</given-names></name><name><surname>Bassi</surname><given-names>J</given-names></name><name><surname>Pinto</surname><given-names>D</given-names></name><name><surname>Fregni</surname><given-names>CS</given-names></name><etal/></person-group><article-title>Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies</article-title><source>Nature</source><year>2021</year><pub-id pub-id-type="pmid">33706364</pub-id></element-citation></ref><ref id="R11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Corbett</surname><given-names>KS</given-names></name><name><surname>Edwards</surname><given-names>DK</given-names></name><name><surname>Leist</surname><given-names>SR</given-names></name><name><surname>Abiona</surname><given-names>OM</given-names></name><name><surname>Boyoglu-Barnum</surname><given-names>S</given-names></name><name><surname>Gillespie</surname><given-names>RA</given-names></name><name><surname>Himansu</surname><given-names>S</given-names></name><name><surname>Schäfer</surname><given-names>A</given-names></name><name><surname>Ziwawo</surname><given-names>CT</given-names></name><name><surname>DiPiazza</surname><given-names>AT</given-names></name><etal/></person-group><article-title>SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness</article-title><source>Nature</source><year>2020</year><volume>586</volume><fpage>567</fpage><lpage>571</lpage><pub-id pub-id-type="pmcid">PMC7581537</pub-id><pub-id pub-id-type="pmid">32756549</pub-id><pub-id pub-id-type="doi">10.1038/s41586-020-2622-0</pub-id></element-citation></ref><ref id="R12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Corti</surname><given-names>D</given-names></name><name><surname>Purcell</surname><given-names>LA</given-names></name><name><surname>Snell</surname><given-names>G</given-names></name><name><surname>Veesler</surname><given-names>D</given-names></name></person-group><article-title>Tackling COVID-19 with neutralizing monoclonal antibodies</article-title><source>Cell</source><year>2021</year><pub-id pub-id-type="pmcid">PMC8375150</pub-id><pub-id pub-id-type="pmid">34416148</pub-id><pub-id pub-id-type="doi">10.1016/j.cell.2021.07.027</pub-id></element-citation></ref><ref id="R13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davies</surname><given-names>NG</given-names></name><name><surname>Abbott</surname><given-names>S</given-names></name><name><surname>Barnard</surname><given-names>RC</given-names></name><name><surname>Jarvis</surname><given-names>CI</given-names></name><name><surname>Kucharski</surname><given-names>AJ</given-names></name><name><surname>Munday</surname><given-names>JD</given-names></name><name><surname>Pearson</surname><given-names>CAB</given-names></name><name><surname>Russell</surname><given-names>TW</given-names></name><name><surname>Tully</surname><given-names>DC</given-names></name><name><surname>Washburne</surname><given-names>AD</given-names></name><etal/></person-group><article-title>Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England</article-title><source>Science</source><year>2021</year><pub-id pub-id-type="pmcid">PMC8128288</pub-id><pub-id pub-id-type="pmid">33658326</pub-id><pub-id pub-id-type="doi">10.1126/science.abg3055</pub-id></element-citation></ref><ref id="R14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Delmas</surname><given-names>B</given-names></name><name><surname>Gelfi</surname><given-names>J</given-names></name><name><surname>L’Haridon</surname><given-names>R</given-names></name><name><surname>Vogel</surname></name><name><surname>Sjöström</surname><given-names>H</given-names></name><name><surname>Norén</surname></name><name><surname>Laude</surname><given-names>H</given-names></name></person-group><article-title>Aminopeptidase N is a major receptor for the enteropathogenic coronavirus TGEV</article-title><source>Nature</source><year>1992</year><volume>357</volume><fpage>417</fpage><lpage>420</lpage><pub-id pub-id-type="pmcid">PMC7095137</pub-id><pub-id pub-id-type="pmid">1350661</pub-id><pub-id pub-id-type="doi">10.1038/357417a0</pub-id></element-citation></ref><ref id="R15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deng</surname><given-names>X</given-names></name><name><surname>Garcia-Knight</surname><given-names>MA</given-names></name><name><surname>Khalid</surname><given-names>MM</given-names></name><name><surname>Servellita</surname><given-names>V</given-names></name><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Morris</surname><given-names>MK</given-names></name><name><surname>Sotomayor-González</surname><given-names>A</given-names></name><name><surname>Glasner</surname><given-names>DR</given-names></name><name><surname>Reyes</surname><given-names>KR</given-names></name><name><surname>Gliwa</surname><given-names>AS</given-names></name><etal/></person-group><article-title>Transmission, infectivity, and neutralization of a spike L452R SARS-CoV-2 variant</article-title><source>Cell</source><year>2021</year><pub-id pub-id-type="pmcid">PMC8057738</pub-id><pub-id pub-id-type="pmid">33991487</pub-id><pub-id pub-id-type="doi">10.1016/j.cell.2021.04.025</pub-id></element-citation></ref><ref id="R16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Edara</surname><given-names>V-V</given-names></name><name><surname>Pinsky</surname><given-names>BA</given-names></name><name><surname>Suthar</surname><given-names>MS</given-names></name><name><surname>Lai</surname><given-names>L</given-names></name><name><surname>Davis-Gardner</surname><given-names>ME</given-names></name><name><surname>Floyd</surname><given-names>K</given-names></name><name><surname>Flowers</surname><given-names>MW</given-names></name><name><surname>Wrammert</surname><given-names>J</given-names></name><name><surname>Hussaini</surname><given-names>L</given-names></name><name><surname>Ciric</surname><given-names>CR</given-names></name><etal/></person-group><article-title>Infection and Vaccine-Induced Neutralizing-Antibody Responses to the SARS-CoV-2 B.1.617 Variants</article-title><source>N Engl J Med</source><year>2021</year><pub-id pub-id-type="pmcid">PMC8279090</pub-id><pub-id pub-id-type="pmid">34233096</pub-id><pub-id pub-id-type="doi">10.1056/NEJMc2107799</pub-id></element-citation></ref><ref id="R17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eguia</surname><given-names>RT</given-names></name><name><surname>Crawford</surname><given-names>KHD</given-names></name><name><surname>Stevens-Ayers</surname><given-names>T</given-names></name><name><surname>Kelnhofer-Millevolte</surname><given-names>L</given-names></name><name><surname>Greninger</surname><given-names>AL</given-names></name><name><surname>Englund</surname><given-names>JA</given-names></name><name><surname>Boeckh</surname><given-names>MJ</given-names></name><name><surname>Bloom</surname><given-names>JD</given-names></name></person-group><article-title>A human coronavirus evolves antigenically to escape antibody immunity</article-title><source>PLoS Pathog</source><year>2021</year><volume>17</volume><elocation-id>e1009453</elocation-id><pub-id pub-id-type="pmcid">PMC8031418</pub-id><pub-id pub-id-type="pmid">33831132</pub-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1009453</pub-id></element-citation></ref><ref id="R18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Emsley</surname><given-names>P</given-names></name><name><surname>Lohkamp</surname><given-names>B</given-names></name><name><surname>Scott</surname><given-names>WG</given-names></name><name><surname>Cowtan</surname><given-names>K</given-names></name></person-group><article-title>Features and development of Coot</article-title><source>Acta Crystallogr D Biol Crystallogr</source><year>2010</year><volume>66</volume><fpage>486</fpage><lpage>501</lpage><pub-id pub-id-type="pmcid">PMC2852313</pub-id><pub-id pub-id-type="pmid">20383002</pub-id><pub-id pub-id-type="doi">10.1107/S0907444910007493</pub-id></element-citation></ref><ref id="R19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Faria</surname><given-names>NR</given-names></name><name><surname>Mellan</surname><given-names>TA</given-names></name><name><surname>Whittaker</surname><given-names>C</given-names></name><name><surname>Claro</surname><given-names>IM</given-names></name><name><surname>da Candido</surname><given-names>DS</given-names></name><name><surname>Mishra</surname><given-names>S</given-names></name><name><surname>Crispim</surname><given-names>MAE</given-names></name><name><surname>Sales</surname><given-names>FCS</given-names></name><name><surname>Hawryluk</surname><given-names>I</given-names></name><name><surname>McCrone</surname><given-names>JT</given-names></name><etal/></person-group><article-title>Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil</article-title><source>Science</source><year>2021</year><volume>372</volume><fpage>815</fpage><lpage>821</lpage><pub-id pub-id-type="pmcid">PMC8139423</pub-id><pub-id pub-id-type="pmid">33853970</pub-id><pub-id pub-id-type="doi">10.1126/science.abh2644</pub-id></element-citation></ref><ref id="R20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frenz</surname><given-names>B</given-names></name><name><surname>Rämisch</surname><given-names>S</given-names></name><name><surname>Borst</surname><given-names>AJ</given-names></name><name><surname>Walls</surname><given-names>AC</given-names></name><name><surname>Adolf-Bryfogle</surname><given-names>J</given-names></name><name><surname>Schief</surname><given-names>WR</given-names></name><name><surname>Veesler</surname><given-names>D</given-names></name><name><surname>DiMaio</surname><given-names>F</given-names></name></person-group><article-title>Automatically Fixing Errors in Glycoprotein Structures with Rosetta</article-title><source>Structure</source><year>2019</year><volume>27</volume><fpage>134</fpage><lpage>139</lpage><elocation-id>e3</elocation-id><pub-id pub-id-type="pmcid">PMC6616339</pub-id><pub-id pub-id-type="pmid">30344107</pub-id><pub-id pub-id-type="doi">10.1016/j.str.2018.09.006</pub-id></element-citation></ref><ref id="R21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ge</surname><given-names>XY</given-names></name><name><surname>Li</surname><given-names>JL</given-names></name><name><surname>Yang</surname><given-names>XL</given-names></name><name><surname>Chmura</surname><given-names>AA</given-names></name><name><surname>Zhu</surname><given-names>G</given-names></name><name><surname>Epstein</surname><given-names>JH</given-names></name><name><surname>Mazet</surname><given-names>JK</given-names></name><name><surname>Hu</surname><given-names>B</given-names></name><name><surname>Zhang</surname><given-names>W</given-names></name><name><surname>Peng</surname><given-names>C</given-names></name><etal/></person-group><article-title>Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor</article-title><source>Nature</source><year>2013</year><volume>503</volume><fpage>535</fpage><lpage>538</lpage><pub-id pub-id-type="pmcid">PMC5389864</pub-id><pub-id pub-id-type="pmid">24172901</pub-id><pub-id pub-id-type="doi">10.1038/nature12711</pub-id></element-citation></ref><ref id="R22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goddard</surname><given-names>TD</given-names></name><name><surname>Huang</surname><given-names>CC</given-names></name><name><surname>Meng</surname><given-names>EC</given-names></name><name><surname>Pettersen</surname><given-names>EF</given-names></name><name><surname>Couch</surname><given-names>GS</given-names></name><name><surname>Morris</surname><given-names>JH</given-names></name><name><surname>Ferrin</surname><given-names>TE</given-names></name></person-group><article-title>UCSF ChimeraX: Meeting modern challenges in visualization and analysis</article-title><source>Protein Sci</source><year>2018</year><volume>27</volume><fpage>14</fpage><lpage>25</lpage><pub-id pub-id-type="pmcid">PMC5734306</pub-id><pub-id pub-id-type="pmid">28710774</pub-id><pub-id pub-id-type="doi">10.1002/pro.3235</pub-id></element-citation></ref><ref id="R23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guan</surname><given-names>Y</given-names></name><name><surname>Zheng</surname><given-names>BJ</given-names></name><name><surname>He</surname><given-names>YQ</given-names></name><name><surname>Liu</surname><given-names>XL</given-names></name><name><surname>Zhuang</surname><given-names>ZX</given-names></name><name><surname>Cheung</surname><given-names>CL</given-names></name><name><surname>Luo</surname><given-names>SW</given-names></name><name><surname>Li</surname><given-names>PH</given-names></name><name><surname>Zhang</surname><given-names>LJ</given-names></name><name><surname>Guan</surname><given-names>YJ</given-names></name><etal/></person-group><article-title>Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China</article-title><source>Science</source><year>2003</year><volume>302</volume><fpage>276</fpage><lpage>278</lpage><pub-id pub-id-type="pmid">12958366</pub-id></element-citation></ref><ref id="R24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haagmans</surname><given-names>BL</given-names></name><name><surname>Al Dhahiry</surname><given-names>SH</given-names></name><name><surname>Reusken</surname><given-names>CB</given-names></name><name><surname>Raj</surname><given-names>VS</given-names></name><name><surname>Galiano</surname><given-names>M</given-names></name><name><surname>Myers</surname><given-names>R</given-names></name><name><surname>Godeke</surname><given-names>GJ</given-names></name><name><surname>Jonges</surname><given-names>M</given-names></name><name><surname>Farag</surname><given-names>E</given-names></name><name><surname>Diab</surname><given-names>A</given-names></name><etal/></person-group><article-title>Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation</article-title><source>Lancet Infect Dis</source><year>2014</year><volume>14</volume><fpage>140</fpage><lpage>145</lpage><pub-id pub-id-type="pmcid">PMC7106553</pub-id><pub-id pub-id-type="pmid">24355866</pub-id><pub-id pub-id-type="doi">10.1016/S1473-3099(13)70690-X</pub-id></element-citation></ref><ref id="R25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hansen</surname><given-names>J</given-names></name><name><surname>Baum</surname><given-names>A</given-names></name><name><surname>Pascal</surname><given-names>KE</given-names></name><name><surname>Russo</surname><given-names>V</given-names></name><name><surname>Giordano</surname><given-names>S</given-names></name><name><surname>Wloga</surname><given-names>E</given-names></name><name><surname>Fulton</surname><given-names>BO</given-names></name><name><surname>Yan</surname><given-names>Y</given-names></name><name><surname>Koon</surname><given-names>K</given-names></name><name><surname>Patel</surname><given-names>K</given-names></name><etal/></person-group><article-title>Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail</article-title><source>Science</source><year>2020</year><pub-id pub-id-type="pmcid">PMC7299284</pub-id><pub-id pub-id-type="pmid">32540901</pub-id><pub-id pub-id-type="doi">10.1126/science.abd0827</pub-id></element-citation></ref><ref id="R26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hsu</surname><given-names>STD</given-names></name><name><surname>Yang</surname><given-names>TJ</given-names></name><name><surname>Ko</surname><given-names>TP</given-names></name><name><surname>Draczkowski</surname><given-names>P</given-names></name></person-group><article-title>Cryo-EM structure of spike protein of feline infectious peritonitis virus strain UU4</article-title><year>2020</year></element-citation></ref><ref id="R27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hulswit</surname><given-names>RJG</given-names></name><name><surname>Lang</surname><given-names>Y</given-names></name><name><surname>Bakkers</surname><given-names>MJG</given-names></name><name><surname>Li</surname><given-names>W</given-names></name><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Schouten</surname><given-names>A</given-names></name><name><surname>Ophorst</surname><given-names>B</given-names></name><name><surname>van Kuppeveld</surname><given-names>FJM</given-names></name><name><surname>Boons</surname><given-names>GJ</given-names></name><name><surname>Bosch</surname><given-names>BJ</given-names></name><etal/></person-group><article-title>Human coronaviruses OC43 and HKU1 bind to 9-O-acetylated sialic acids via a conserved receptor-binding site in spike protein domain A</article-title><source>Proc Natl Acad Sci U S A</source><year>2019</year><pub-id pub-id-type="pmcid">PMC6377473</pub-id><pub-id pub-id-type="pmid">30679277</pub-id><pub-id pub-id-type="doi">10.1073/pnas.1809667116</pub-id></element-citation></ref><ref id="R28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaname</surname><given-names>Y</given-names></name><name><surname>Tani</surname><given-names>H</given-names></name><name><surname>Kataoka</surname><given-names>C</given-names></name><name><surname>Shiokawa</surname><given-names>M</given-names></name><name><surname>Taguwa</surname><given-names>S</given-names></name><name><surname>Abe</surname><given-names>T</given-names></name><name><surname>Moriishi</surname><given-names>K</given-names></name><name><surname>Kinoshita</surname><given-names>T</given-names></name><name><surname>Matsuura</surname><given-names>Y</given-names></name></person-group><article-title>Acquisition of complement resistance through incorporation of CD55/decay-accelerating factor into viral particles bearing baculovirus GP64</article-title><source>J Virol</source><year>2010</year><volume>84</volume><fpage>3210</fpage><lpage>3219</lpage><pub-id pub-id-type="pmcid">PMC2838113</pub-id><pub-id pub-id-type="pmid">20071581</pub-id><pub-id pub-id-type="doi">10.1128/JVI.02519-09</pub-id></element-citation></ref><ref id="R29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kirchdoerfer</surname><given-names>RN</given-names></name><name><surname>Bhandari</surname><given-names>M</given-names></name><name><surname>Martini</surname><given-names>O</given-names></name><name><surname>Sewall</surname><given-names>LM</given-names></name><name><surname>Bangaru</surname><given-names>S</given-names></name><name><surname>Yoon</surname><given-names>K-J</given-names></name><name><surname>Ward</surname><given-names>AB</given-names></name></person-group><article-title>Structure and immune recognition of the porcine epidemic diarrhea virus spike protein</article-title><source>Structure</source><year>2021</year><volume>29</volume><fpage>385</fpage><lpage>392</lpage><elocation-id>e5</elocation-id><pub-id pub-id-type="pmcid">PMC7962898</pub-id><pub-id pub-id-type="pmid">33378641</pub-id><pub-id pub-id-type="doi">10.1016/j.str.2020.12.003</pub-id></element-citation></ref><ref id="R30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krempl</surname><given-names>C</given-names></name><name><surname>Schultze</surname><given-names>B</given-names></name><name><surname>Laude</surname><given-names>H</given-names></name><name><surname>Herrler</surname><given-names>G</given-names></name></person-group><article-title>Point mutations in the S protein connect the sialic acid binding activity with the enteropathogenicity of transmissible gastroenteritis coronavirus</article-title><source>J Virol</source><year>1997</year><volume>71</volume><fpage>3285</fpage><lpage>3287</lpage><pub-id pub-id-type="pmcid">PMC191465</pub-id><pub-id pub-id-type="pmid">9060696</pub-id><pub-id pub-id-type="doi">10.1128/jvi.71.4.3285-3287.1997</pub-id></element-citation></ref><ref id="R31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lednicky</surname><given-names>JA</given-names></name><name><surname>Tagliamonte</surname><given-names>MS</given-names></name><name><surname>White</surname><given-names>SK</given-names></name><name><surname>Elbadry</surname><given-names>MA</given-names></name><name><surname>Alam</surname><given-names>MM</given-names></name><name><surname>Stephenson</surname><given-names>CJ</given-names></name><name><surname>Bonny</surname><given-names>TS</given-names></name><name><surname>Loeb</surname><given-names>JC</given-names></name><name><surname>Telisma</surname><given-names>T</given-names></name><name><surname>Chavannes</surname><given-names>S</given-names></name><etal/></person-group><article-title>Emergence of porcine deltacoronavirus pathogenic infections among children in Haiti through independent zoonoses and convergent evolution</article-title><source>medRxiv</source><year>2021</year></element-citation></ref><ref id="R32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lempp</surname><given-names>FA</given-names></name><name><surname>Soriaga</surname><given-names>L</given-names></name><name><surname>Montiel-Ruiz</surname><given-names>M</given-names></name><name><surname>Benigni</surname><given-names>F</given-names></name><name><surname>Noack</surname><given-names>J</given-names></name><name><surname>Park</surname><given-names>Y-J</given-names></name><name><surname>Bianchi</surname><given-names>S</given-names></name><name><surname>Walls</surname><given-names>AC</given-names></name><name><surname>Bowen</surname><given-names>JE</given-names></name><name><surname>Zhou</surname><given-names>J</given-names></name><etal/></person-group><article-title>Membrane lectins enhance SARS-CoV-2 infection and influence the neutralizing activity of different classes of antibodies</article-title><source>bioRxiv</source><year>2021</year><pub-id pub-id-type="pmid">34464958</pub-id></element-citation></ref><ref id="R33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>W</given-names></name><name><surname>Hulswit</surname><given-names>RJG</given-names></name><name><surname>Widjaja</surname><given-names>I</given-names></name><name><surname>Raj</surname><given-names>VS</given-names></name><name><surname>McBride</surname><given-names>R</given-names></name><name><surname>Peng</surname><given-names>W</given-names></name><name><surname>Widagdo</surname><given-names>W</given-names></name><name><surname>Tortorici</surname><given-names>MA</given-names></name><name><surname>van Dieren</surname><given-names>B</given-names></name><name><surname>Lang</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Identification of sialic acid-binding function for the Middle East respiratory syndrome coronavirus spike glycoprotein</article-title><source>Proc Natl Acad Sci U S A</source><year>2017</year><volume>114</volume><fpage>E8508</fpage><lpage>E8517</lpage><pub-id pub-id-type="pmcid">PMC5635925</pub-id><pub-id pub-id-type="pmid">28923942</pub-id><pub-id pub-id-type="doi">10.1073/pnas.1712592114</pub-id></element-citation></ref><ref id="R34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>W</given-names></name><name><surname>Hulswit</surname><given-names>RJG</given-names></name><name><surname>Kenney</surname><given-names>SP</given-names></name><name><surname>Widjaja</surname><given-names>I</given-names></name><name><surname>Jung</surname><given-names>K</given-names></name><name><surname>Alhamo</surname><given-names>MA</given-names></name><name><surname>van Dieren</surname><given-names>B</given-names></name><name><surname>van Kuppeveld</surname><given-names>FJM</given-names></name><name><surname>Saif</surname><given-names>LJ</given-names></name><name><surname>Bosch</surname><given-names>BJ</given-names></name></person-group><article-title>Broad receptor engagement of an emerging global coronavirus may potentiate its diverse cross-species transmissibility</article-title><source>Proc Natl Acad Sci U S A</source><year>2018</year><volume>115</volume><fpage>E5135</fpage><lpage>E5143</lpage><pub-id pub-id-type="pmcid">PMC5984533</pub-id><pub-id pub-id-type="pmid">29760102</pub-id><pub-id pub-id-type="doi">10.1073/pnas.1802879115</pub-id></element-citation></ref><ref id="R35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Tomlinson</surname><given-names>AC</given-names></name><name><surname>Wong</surname><given-names>AH</given-names></name><name><surname>Zhou</surname><given-names>D</given-names></name><name><surname>Desforges</surname><given-names>M</given-names></name><name><surname>Talbot</surname><given-names>PJ</given-names></name><name><surname>Benlekbir</surname><given-names>S</given-names></name><name><surname>Rubinstein</surname><given-names>JL</given-names></name><name><surname>Rini</surname><given-names>JM</given-names></name></person-group><article-title>The human coronavirus HCoV-229E S-protein structure and receptor binding</article-title><source>Elife</source><year>2019</year><volume>8</volume><pub-id pub-id-type="pmcid">PMC6970540</pub-id><pub-id pub-id-type="pmid">31650956</pub-id><pub-id pub-id-type="doi">10.7554/eLife.51230</pub-id></element-citation></ref><ref id="R36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Licitra</surname><given-names>BN</given-names></name><name><surname>Millet</surname><given-names>JK</given-names></name><name><surname>Regan</surname><given-names>AD</given-names></name><name><surname>Hamilton</surname><given-names>BS</given-names></name><name><surname>Rinaldi</surname><given-names>VD</given-names></name><name><surname>Duhamel</surname><given-names>GE</given-names></name><name><surname>Whittaker</surname><given-names>GR</given-names></name></person-group><article-title>Mutation in spike protein cleavage site and pathogenesis of feline coronavirus</article-title><source>Emerg Infect Dis</source><year>2013</year><volume>19</volume><fpage>1066</fpage><lpage>1073</lpage><pub-id pub-id-type="pmcid">PMC3713968</pub-id><pub-id pub-id-type="pmid">23763835</pub-id><pub-id pub-id-type="doi">10.3201/eid1907.121094</pub-id></element-citation></ref><ref id="R37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>C</given-names></name><name><surname>Ginn</surname><given-names>HM</given-names></name><name><surname>Dejnirattisai</surname><given-names>W</given-names></name><name><surname>Supasa</surname><given-names>P</given-names></name><name><surname>Wang</surname><given-names>B</given-names></name><name><surname>Tuekprakhon</surname><given-names>A</given-names></name><name><surname>Nutalai</surname><given-names>R</given-names></name><name><surname>Zhou</surname><given-names>D</given-names></name><name><surname>Mentzer</surname><given-names>AJ</given-names></name><name><surname>Zhao</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum</article-title><source>Cell</source><year>2021a</year><pub-id pub-id-type="pmcid">PMC8218332</pub-id><pub-id pub-id-type="pmid">34242578</pub-id><pub-id pub-id-type="doi">10.1016/j.cell.2021.06.020</pub-id></element-citation></ref><ref id="R38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Johnson</surname><given-names>BA</given-names></name><name><surname>Xia</surname><given-names>H</given-names></name><name><surname>Ku</surname><given-names>Z</given-names></name><name><surname>Schindewolf</surname><given-names>C</given-names></name><name><surname>Widen</surname><given-names>SG</given-names></name><name><surname>An</surname><given-names>Z</given-names></name><name><surname>Weaver</surname><given-names>SC</given-names></name><name><surname>Menachery</surname><given-names>VD</given-names></name><etal/></person-group><article-title>Delta spike P681R mutation enhances SARS-CoV-2 fitness over Alpha variant</article-title><source>bioRxiv</source><year>2021b</year><pub-id pub-id-type="pmcid">PMC9050581</pub-id><pub-id pub-id-type="pmid">35550680</pub-id><pub-id pub-id-type="doi">10.1016/j.celrep.2022.110829</pub-id></element-citation></ref><ref id="R39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCallum</surname><given-names>M</given-names></name><name><surname>De Marco</surname><given-names>A</given-names></name><name><surname>Lempp</surname><given-names>FA</given-names></name><name><surname>Tortorici</surname><given-names>MA</given-names></name><name><surname>Pinto</surname><given-names>D</given-names></name><name><surname>Walls</surname><given-names>AC</given-names></name><name><surname>Beltramello</surname><given-names>M</given-names></name><name><surname>Chen</surname><given-names>A</given-names></name><name><surname>Liu</surname><given-names>Z</given-names></name><name><surname>Zatta</surname><given-names>F</given-names></name><etal/></person-group><article-title>N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2</article-title><source>Cell</source><year>2021a</year><pub-id pub-id-type="pmcid">PMC7962585</pub-id><pub-id pub-id-type="pmid">33761326</pub-id><pub-id pub-id-type="doi">10.1016/j.cell.2021.03.028</pub-id></element-citation></ref><ref id="R40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCallum</surname><given-names>M</given-names></name><name><surname>Bassi</surname><given-names>J</given-names></name><name><surname>De Marco</surname><given-names>A</given-names></name><name><surname>Chen</surname><given-names>A</given-names></name><name><surname>Walls</surname><given-names>AC</given-names></name><name><surname>Di Iulio</surname><given-names>J</given-names></name><name><surname>Tortorici</surname><given-names>MA</given-names></name><name><surname>Navarro</surname><given-names>M-J</given-names></name><name><surname>Silacci-Fregni</surname><given-names>C</given-names></name><name><surname>Saliba</surname><given-names>C</given-names></name><etal/></person-group><article-title>SARS-CoV-2 immune evasion by the B.1.427/B.1.429 variant of concern</article-title><source>Science</source><year>2021b</year><pub-id pub-id-type="pmcid">PMC9835956</pub-id><pub-id pub-id-type="pmid">34210893</pub-id><pub-id pub-id-type="doi">10.1126/science.abi7994</pub-id></element-citation></ref><ref id="R41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Memish</surname><given-names>ZA</given-names></name><name><surname>Mishra</surname><given-names>N</given-names></name><name><surname>Olival</surname><given-names>KJ</given-names></name><name><surname>Fagbo</surname><given-names>SF</given-names></name><name><surname>Kapoor</surname><given-names>V</given-names></name><name><surname>Epstein</surname><given-names>JH</given-names></name><name><surname>Alhakeem</surname><given-names>R</given-names></name><name><surname>Durosinloun</surname><given-names>A</given-names></name><name><surname>Al Asmari</surname><given-names>M</given-names></name><name><surname>Islam</surname><given-names>A</given-names></name><etal/></person-group><article-title>Middle East respiratory syndrome coronavirus in bats, Saudi Arabia</article-title><source>Emerg Infect Dis</source><year>2013</year><volume>19</volume><fpage>1819</fpage><lpage>1823</lpage><pub-id pub-id-type="pmcid">PMC3837665</pub-id><pub-id pub-id-type="pmid">24206838</pub-id><pub-id pub-id-type="doi">10.3201/eid1911.131172</pub-id></element-citation></ref><ref id="R42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Menachery</surname><given-names>VD</given-names></name><name><surname>Yount</surname><given-names>BL</given-names><suffix>Jr</suffix></name><name><surname>Debbink</surname><given-names>K</given-names></name><name><surname>Agnihothram</surname><given-names>S</given-names></name><name><surname>Gralinski</surname><given-names>LE</given-names></name><name><surname>Plante</surname><given-names>JA</given-names></name><name><surname>Graham</surname><given-names>RL</given-names></name><name><surname>Scobey</surname><given-names>T</given-names></name><name><surname>Ge</surname><given-names>XY</given-names></name><name><surname>Donaldson</surname><given-names>EF</given-names></name><etal/></person-group><article-title>A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence</article-title><source>Nat Med</source><year>2015</year><volume>21</volume><fpage>1508</fpage><lpage>1513</lpage><pub-id pub-id-type="pmcid">PMC4797993</pub-id><pub-id pub-id-type="pmid">26552008</pub-id><pub-id pub-id-type="doi">10.1038/nm.3985</pub-id></element-citation></ref><ref id="R43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Menachery</surname><given-names>VD</given-names></name><name><surname>Yount</surname><given-names>BL</given-names><suffix>Jr</suffix></name><name><surname>Sims</surname><given-names>AC</given-names></name><name><surname>Debbink</surname><given-names>K</given-names></name><name><surname>Agnihothram</surname><given-names>SS</given-names></name><name><surname>Gralinski</surname><given-names>LE</given-names></name><name><surname>Graham</surname><given-names>RL</given-names></name><name><surname>Scobey</surname><given-names>T</given-names></name><name><surname>Plante</surname><given-names>JA</given-names></name><name><surname>Royal</surname><given-names>SR</given-names></name><etal/></person-group><article-title>SARS-like WIV1-CoV poised for human emergence</article-title><source>Proc Natl Acad Sci U S A</source><year>2016</year><volume>113</volume><fpage>3048</fpage><lpage>3053</lpage><pub-id pub-id-type="pmcid">PMC4801244</pub-id><pub-id pub-id-type="pmid">26976607</pub-id><pub-id pub-id-type="doi">10.1073/pnas.1517719113</pub-id></element-citation></ref><ref id="R44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Menachery</surname><given-names>VD</given-names></name><name><surname>Dinnon</surname><given-names>KH</given-names></name><name><surname>Yount</surname><given-names>BL</given-names></name><name><surname>McAnarney</surname><given-names>ET</given-names></name><name><surname>Gralinski</surname><given-names>LE</given-names></name><name><surname>Hale</surname><given-names>A</given-names></name><name><surname>Graham</surname><given-names>RL</given-names></name><name><surname>Scobey</surname><given-names>T</given-names></name><name><surname>Anthony</surname><given-names>SJ</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><etal/></person-group><article-title>Trypsin Treatment Unlocks Barrier for Zoonotic Bat Coronavirus Infection</article-title><source>J Virol</source><year>2020</year><volume>94</volume><pub-id pub-id-type="pmcid">PMC7022341</pub-id><pub-id pub-id-type="pmid">31801868</pub-id><pub-id pub-id-type="doi">10.1128/JVI.01774-19</pub-id></element-citation></ref><ref id="R45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Milewska</surname><given-names>A</given-names></name><name><surname>Zarebski</surname><given-names>M</given-names></name><name><surname>Nowak</surname><given-names>P</given-names></name><name><surname>Stozek</surname><given-names>K</given-names></name><name><surname>Potempa</surname><given-names>J</given-names></name><name><surname>Pyrc</surname><given-names>K</given-names></name></person-group><article-title>Human coronavirus NL63 utilizes heparan sulfate proteoglycans for attachment to target cells</article-title><source>J Virol</source><year>2014</year><volume>88</volume><fpage>13221</fpage><lpage>13230</lpage><pub-id pub-id-type="pmcid">PMC4249106</pub-id><pub-id pub-id-type="pmid">25187545</pub-id><pub-id pub-id-type="doi">10.1128/JVI.02078-14</pub-id></element-citation></ref><ref id="R46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Millet</surname><given-names>JK</given-names></name><name><surname>Whittaker</surname><given-names>GR</given-names></name></person-group><article-title>Host cell entry of Middle East respiratory syndrome coronavirus after two-step, furin-mediated activation of the spike protein</article-title><source>Proc Natl Acad Sci U S A</source><year>2014</year><volume>111</volume><fpage>15214</fpage><lpage>15219</lpage><pub-id pub-id-type="pmcid">PMC4210292</pub-id><pub-id pub-id-type="pmid">25288733</pub-id><pub-id pub-id-type="doi">10.1073/pnas.1407087111</pub-id></element-citation></ref><ref id="R47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Millet</surname><given-names>JK</given-names></name><name><surname>Whittaker</surname><given-names>GR</given-names></name></person-group><article-title>Host cell proteases: Critical determinants of coronavirus tropism and pathogenesis</article-title><source>Virus Res</source><year>2015</year><volume>202</volume><fpage>120</fpage><lpage>134</lpage><pub-id pub-id-type="pmcid">PMC4465284</pub-id><pub-id pub-id-type="pmid">25445340</pub-id><pub-id pub-id-type="doi">10.1016/j.virusres.2014.11.021</pub-id></element-citation></ref><ref id="R48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>YJ</given-names></name><name><surname>Walls</surname><given-names>AC</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Sauer</surname><given-names>MM</given-names></name><name><surname>Li</surname><given-names>W</given-names></name><name><surname>Tortorici</surname><given-names>MA</given-names></name><name><surname>Bosch</surname><given-names>BJ</given-names></name><name><surname>DiMaio</surname><given-names>F</given-names></name><name><surname>Veesler</surname><given-names>D</given-names></name></person-group><article-title>Structures of MERS-CoV spike glycoprotein in complex with sialoside attachment receptors</article-title><source>Nat Struct Mol Biol</source><year>2019</year><volume>26</volume><fpage>1151</fpage><lpage>1157</lpage><pub-id pub-id-type="pmcid">PMC7097669</pub-id><pub-id pub-id-type="pmid">31792450</pub-id><pub-id pub-id-type="doi">10.1038/s41594-019-0334-7</pub-id></element-citation></ref><ref id="R49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peng</surname><given-names>G</given-names></name><name><surname>Sun</surname><given-names>D</given-names></name><name><surname>Rajashankar</surname><given-names>KR</given-names></name><name><surname>Qian</surname><given-names>Z</given-names></name><name><surname>Holmes</surname><given-names>KV</given-names></name><name><surname>Li</surname><given-names>F</given-names></name></person-group><article-title>Crystal structure of mouse coronavirus receptor-binding domain complexed with its murine receptor</article-title><source>Proc Natl Acad Sci U S A</source><year>2011</year><volume>108</volume><fpage>10696</fpage><lpage>10701</lpage><pub-id pub-id-type="pmcid">PMC3127895</pub-id><pub-id pub-id-type="pmid">21670291</pub-id><pub-id pub-id-type="doi">10.1073/pnas.1104306108</pub-id></element-citation></ref><ref id="R50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pettersen</surname><given-names>EF</given-names></name><name><surname>Goddard</surname><given-names>TD</given-names></name><name><surname>Huang</surname><given-names>CC</given-names></name><name><surname>Couch</surname><given-names>GS</given-names></name><name><surname>Greenblatt</surname><given-names>DM</given-names></name><name><surname>Meng</surname><given-names>EC</given-names></name><name><surname>Ferrin</surname><given-names>TE</given-names></name></person-group><article-title>UCSF Chimera--a visualization system for exploratory research and analysis</article-title><source>J Comput Chem</source><year>2004</year><volume>25</volume><fpage>1605</fpage><lpage>1612</lpage><pub-id pub-id-type="pmid">15264254</pub-id></element-citation></ref><ref id="R51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Piccoli</surname><given-names>L</given-names></name><name><surname>Park</surname><given-names>YJ</given-names></name><name><surname>Tortorici</surname><given-names>MA</given-names></name><name><surname>Czudnochowski</surname><given-names>N</given-names></name><name><surname>Walls</surname><given-names>AC</given-names></name><name><surname>Beltramello</surname><given-names>M</given-names></name><name><surname>Silacci-Fregni</surname><given-names>C</given-names></name><name><surname>Pinto</surname><given-names>D</given-names></name><name><surname>Rosen</surname><given-names>LE</given-names></name><name><surname>Bowen</surname><given-names>JE</given-names></name><etal/></person-group><article-title>Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology</article-title><source>Cell</source><year>2020</year><volume>183</volume><fpage>1024</fpage><lpage>1042</lpage><elocation-id>e21</elocation-id><pub-id pub-id-type="pmcid">PMC7494283</pub-id><pub-id pub-id-type="pmid">32991844</pub-id><pub-id pub-id-type="doi">10.1016/j.cell.2020.09.037</pub-id></element-citation></ref><ref id="R52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pinto</surname><given-names>D</given-names></name><name><surname>Park</surname><given-names>YJ</given-names></name><name><surname>Beltramello</surname><given-names>M</given-names></name><name><surname>Walls</surname><given-names>AC</given-names></name><name><surname>Tortorici</surname><given-names>MA</given-names></name><name><surname>Bianchi</surname><given-names>S</given-names></name><name><surname>Jaconi</surname><given-names>S</given-names></name><name><surname>Culap</surname><given-names>K</given-names></name><name><surname>Zatta</surname><given-names>F</given-names></name><name><surname>De Marco</surname><given-names>A</given-names></name><etal/></person-group><article-title>Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody</article-title><source>Nature</source><year>2020</year><volume>583</volume><fpage>290</fpage><lpage>295</lpage><pub-id pub-id-type="pmid">32422645</pub-id></element-citation></ref><ref id="R53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Plante</surname><given-names>JA</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Xia</surname><given-names>H</given-names></name><name><surname>Johnson</surname><given-names>BA</given-names></name><name><surname>Lokugamage</surname><given-names>KG</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Muruato</surname><given-names>AE</given-names></name><name><surname>Zou</surname><given-names>J</given-names></name><name><surname>Fontes-Garfias</surname><given-names>CR</given-names></name><etal/></person-group><article-title>Spike mutation D614G alters SARS-CoV-2 fitness</article-title><source>Nature</source><year>2020</year><pub-id pub-id-type="pmcid">PMC8158177</pub-id><pub-id pub-id-type="pmid">33106671</pub-id><pub-id pub-id-type="doi">10.1038/s41586-020-2895-3</pub-id></element-citation></ref><ref id="R54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Polack</surname><given-names>FP</given-names></name><name><surname>Thomas</surname><given-names>SJ</given-names></name><name><surname>Kitchin</surname><given-names>N</given-names></name><name><surname>Absalon</surname><given-names>J</given-names></name><name><surname>Gurtman</surname><given-names>A</given-names></name><name><surname>Lockhart</surname><given-names>S</given-names></name><name><surname>Perez</surname><given-names>JL</given-names></name><name><surname>Pérez Marc</surname><given-names>G</given-names></name><name><surname>Moreira</surname><given-names>ED</given-names></name><name><surname>Zerbini</surname><given-names>C</given-names></name><etal/></person-group><article-title>Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine</article-title><source>N Engl J Med</source><year>2020</year><volume>383</volume><fpage>2603</fpage><lpage>2615</lpage><pub-id pub-id-type="pmcid">PMC7745181</pub-id><pub-id pub-id-type="pmid">33301246</pub-id><pub-id pub-id-type="doi">10.1056/NEJMoa2034577</pub-id></element-citation></ref><ref id="R55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Punjani</surname><given-names>A</given-names></name><name><surname>Rubinstein</surname><given-names>JL</given-names></name><name><surname>Fleet</surname><given-names>DJ</given-names></name><name><surname>Brubaker</surname><given-names>MA</given-names></name></person-group><article-title>cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination</article-title><source>Nat Methods</source><year>2017</year><volume>14</volume><fpage>290</fpage><lpage>296</lpage><pub-id pub-id-type="pmid">28165473</pub-id></element-citation></ref><ref id="R56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Punjani</surname><given-names>A</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Fleet</surname><given-names>DJ</given-names></name></person-group><article-title>Non-uniform refinement: adaptive regularization improves single-particle cryo-EM reconstruction</article-title><source>Nat Methods</source><year>2020</year><volume>17</volume><fpage>1214</fpage><lpage>1221</lpage><pub-id pub-id-type="pmid">33257830</pub-id></element-citation></ref><ref id="R57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Regan</surname><given-names>AD</given-names></name><name><surname>Whittaker</surname><given-names>GR</given-names></name></person-group><article-title>Utilization of DC-SIGN for entry of feline coronaviruses into host cells</article-title><source>J Virol</source><year>2008</year><volume>82</volume><fpage>11992</fpage><lpage>11996</lpage><pub-id pub-id-type="pmcid">PMC2583691</pub-id><pub-id pub-id-type="pmid">18799586</pub-id><pub-id pub-id-type="doi">10.1128/JVI.01094-08</pub-id></element-citation></ref><ref id="R58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Regan</surname><given-names>AD</given-names></name><name><surname>Ousterout</surname><given-names>DG</given-names></name><name><surname>Whittaker</surname><given-names>GR</given-names></name></person-group><article-title>Feline lectin activity is critical for the cellular entry of feline infectious peritonitis virus</article-title><source>J Virol</source><year>2010</year><volume>84</volume><fpage>7917</fpage><lpage>7921</lpage><pub-id pub-id-type="pmcid">PMC2897608</pub-id><pub-id pub-id-type="pmid">20484511</pub-id><pub-id pub-id-type="doi">10.1128/JVI.00964-10</pub-id></element-citation></ref><ref id="R59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reguera</surname><given-names>J</given-names></name><name><surname>Santiago</surname><given-names>C</given-names></name><name><surname>Mudgal</surname><given-names>G</given-names></name><name><surname>Ordono</surname><given-names>D</given-names></name><name><surname>Enjuanes</surname><given-names>L</given-names></name><name><surname>Casasnovas</surname><given-names>JM</given-names></name></person-group><article-title>Structural bases of coronavirus attachment to host aminopeptidase N and its inhibition by neutralizing antibodies</article-title><source>PLoS Pathog</source><year>2012</year><volume>8</volume><elocation-id>e1002859</elocation-id><pub-id pub-id-type="pmcid">PMC3410853</pub-id><pub-id pub-id-type="pmid">22876187</pub-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1002859</pub-id></element-citation></ref><ref id="R60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosenthal</surname><given-names>PB</given-names></name><name><surname>Henderson</surname><given-names>R</given-names></name></person-group><article-title>Optimal determination of particle orientation, absolute hand, and contrast loss in single-particle electron cryomicroscopy</article-title><source>J Mol Biol</source><year>2003</year><volume>333</volume><fpage>721</fpage><lpage>745</lpage><pub-id pub-id-type="pmid">14568533</pub-id></element-citation></ref><ref id="R61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shang</surname><given-names>J</given-names></name><name><surname>Zheng</surname><given-names>Y</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>C</given-names></name><name><surname>Geng</surname><given-names>Q</given-names></name><name><surname>Tai</surname><given-names>W</given-names></name><name><surname>Du</surname><given-names>L</given-names></name><name><surname>Zhou</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>W</given-names></name><name><surname>Li</surname><given-names>F</given-names></name></person-group><article-title>Cryo-electron microscopy structure of porcine Deltacoronavirus spike protein in the prefusion state</article-title><source>J Virol</source><year>2018</year><volume>92</volume><pub-id pub-id-type="pmcid">PMC5790952</pub-id><pub-id pub-id-type="pmid">29070693</pub-id><pub-id pub-id-type="doi">10.1128/JVI.01556-17</pub-id></element-citation></ref><ref id="R62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Silva</surname><given-names>CS</given-names></name><name><surname>Mullis</surname><given-names>LB</given-names></name></person-group><article-title>Human Respiratory Coronaviruses Detected In Patients with InfluenzaLike Illness in Arkansas, USA</article-title><source>Virology &amp; Mycology</source><year>2014</year><volume>01</volume><pub-id pub-id-type="pmcid">PMC5004774</pub-id><pub-id pub-id-type="pmid">27588218</pub-id><pub-id pub-id-type="doi">10.4172/2161-0517.S2-004</pub-id></element-citation></ref><ref id="R63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suloway</surname><given-names>C</given-names></name><name><surname>Pulokas</surname><given-names>J</given-names></name><name><surname>Fellmann</surname><given-names>D</given-names></name><name><surname>Cheng</surname><given-names>A</given-names></name><name><surname>Guerra</surname><given-names>F</given-names></name><name><surname>Quispe</surname><given-names>J</given-names></name><name><surname>Stagg</surname><given-names>S</given-names></name><name><surname>Potter</surname><given-names>CS</given-names></name><name><surname>Carragher</surname><given-names>B</given-names></name></person-group><article-title>Automated molecular microscopy: the new Leginon system</article-title><source>J Struct Biol</source><year>2005</year><volume>151</volume><fpage>41</fpage><lpage>60</lpage><pub-id pub-id-type="pmid">15890530</pub-id></element-citation></ref><ref id="R64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tegally</surname><given-names>H</given-names></name><name><surname>Wilkinson</surname><given-names>E</given-names></name><name><surname>Giovanetti</surname><given-names>M</given-names></name><name><surname>Iranzadeh</surname><given-names>A</given-names></name><name><surname>Fonseca</surname><given-names>V</given-names></name><name><surname>Giandhari</surname><given-names>J</given-names></name><name><surname>Doolabh</surname><given-names>D</given-names></name><name><surname>Pillay</surname><given-names>S</given-names></name><name><surname>San</surname><given-names>EJ</given-names></name><name><surname>Msomi</surname><given-names>N</given-names></name><etal/></person-group><article-title>Emergence of a SARS-CoV-2 variant of concern with mutations in spike glycoprotein</article-title><source>Nature</source><year>2021</year></element-citation></ref><ref id="R65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tegunov</surname><given-names>D</given-names></name><name><surname>Cramer</surname><given-names>P</given-names></name></person-group><article-title>Real-time cryo-electron microscopy data preprocessing with Warp</article-title><source>Nat Methods</source><year>2019</year><volume>16</volume><fpage>1146</fpage><lpage>1152</lpage><pub-id pub-id-type="pmcid">PMC6858868</pub-id><pub-id pub-id-type="pmid">31591575</pub-id><pub-id pub-id-type="doi">10.1038/s41592-019-0580-y</pub-id></element-citation></ref><ref id="R66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thomson</surname><given-names>EC</given-names></name><name><surname>Rosen</surname><given-names>LE</given-names></name><name><surname>Shepherd</surname><given-names>JG</given-names></name><name><surname>Spreafico</surname><given-names>R</given-names></name><name><surname>da Silva Filipe</surname><given-names>A</given-names></name><name><surname>Wojcechowskyj</surname><given-names>JA</given-names></name><name><surname>Davis</surname><given-names>C</given-names></name><name><surname>Piccoli</surname><given-names>L</given-names></name><name><surname>Pascall</surname><given-names>DJ</given-names></name><name><surname>Dillen</surname><given-names>J</given-names></name><etal/></person-group><article-title>Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity</article-title><source>Cell</source><year>2021</year><pub-id pub-id-type="pmcid">PMC7843029</pub-id><pub-id pub-id-type="pmid">33621484</pub-id><pub-id pub-id-type="doi">10.1016/j.cell.2021.01.037</pub-id></element-citation></ref><ref id="R67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tortorici</surname><given-names>MA</given-names></name><name><surname>Veesler</surname><given-names>D</given-names></name></person-group><article-title>Structural insights into coronavirus entry</article-title><source>Adv Virus Res</source><year>2019</year><volume>105</volume><fpage>93</fpage><lpage>116</lpage><pub-id pub-id-type="pmcid">PMC7112261</pub-id><pub-id pub-id-type="pmid">31522710</pub-id><pub-id pub-id-type="doi">10.1016/bs.aivir.2019.08.002</pub-id></element-citation></ref><ref id="R68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tortorici</surname><given-names>MA</given-names></name><name><surname>Walls</surname><given-names>AC</given-names></name><name><surname>Lang</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Koerhuis</surname><given-names>D</given-names></name><name><surname>Boons</surname><given-names>GJ</given-names></name><name><surname>Bosch</surname><given-names>BJ</given-names></name><name><surname>Rey</surname><given-names>FA</given-names></name><name><surname>de Groot</surname><given-names>RJ</given-names></name><etal/></person-group><article-title>Structural basis for human coronavirus attachment to sialic acid receptors</article-title><source>Nat Struct Mol Biol</source><year>2019</year><volume>26</volume><fpage>481</fpage><lpage>489</lpage><pub-id pub-id-type="pmcid">PMC6554059</pub-id><pub-id pub-id-type="pmid">31160783</pub-id><pub-id pub-id-type="doi">10.1038/s41594-019-0233-y</pub-id></element-citation></ref><ref id="R69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tortorici</surname><given-names>MA</given-names></name><name><surname>Beltramello</surname><given-names>M</given-names></name><name><surname>Lempp</surname><given-names>FA</given-names></name><name><surname>Pinto</surname><given-names>D</given-names></name><name><surname>Dang</surname><given-names>HV</given-names></name><name><surname>Rosen</surname><given-names>LE</given-names></name><name><surname>McCallum</surname><given-names>M</given-names></name><name><surname>Bowen</surname><given-names>J</given-names></name><name><surname>Minola</surname><given-names>A</given-names></name><name><surname>Jaconi</surname><given-names>S</given-names></name><etal/></person-group><article-title>Ultrapotent human antibodies protect against SARS-CoV-2 challenge via multiple mechanisms</article-title><source>Science</source><year>2020</year><volume>370</volume><fpage>950</fpage><lpage>957</lpage><pub-id pub-id-type="pmcid">PMC7857395</pub-id><pub-id pub-id-type="pmid">32972994</pub-id><pub-id pub-id-type="doi">10.1126/science.abe3354</pub-id></element-citation></ref><ref id="R70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tortorici</surname><given-names>MA</given-names></name><name><surname>Czudnochowski</surname><given-names>N</given-names></name><name><surname>Starr</surname><given-names>TN</given-names></name><name><surname>Marzi</surname><given-names>R</given-names></name><name><surname>Walls</surname><given-names>AC</given-names></name><name><surname>Zatta</surname><given-names>F</given-names></name><name><surname>Bowen</surname><given-names>JE</given-names></name><name><surname>Jaconi</surname><given-names>S</given-names></name><name><surname>Di Iulio</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><etal/></person-group><article-title>Broad sarbecovirus neutralization by a human monoclonal antibody</article-title><source>Nature</source><year>2021</year><pub-id pub-id-type="pmcid">PMC9341430</pub-id><pub-id pub-id-type="pmid">34280951</pub-id><pub-id pub-id-type="doi">10.1038/s41586-021-03817-4</pub-id></element-citation></ref><ref id="R71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tusell</surname><given-names>SM</given-names></name><name><surname>Schittone</surname><given-names>SA</given-names></name><name><surname>Holmes</surname><given-names>KV</given-names></name></person-group><article-title>Mutational analysis of aminopeptidase N, a receptor for several group 1 coronaviruses, identifies key determinants of viral host range</article-title><source>J Virol</source><year>2007</year><volume>81</volume><fpage>1261</fpage><lpage>1273</lpage><pub-id pub-id-type="pmcid">PMC1797531</pub-id><pub-id pub-id-type="pmid">17093189</pub-id><pub-id pub-id-type="doi">10.1128/JVI.01510-06</pub-id></element-citation></ref><ref id="R72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vijgen</surname><given-names>L</given-names></name><name><surname>Keyaerts</surname><given-names>E</given-names></name><name><surname>Zlateva</surname><given-names>K</given-names></name><name><surname>Van Ranst</surname><given-names>M</given-names></name></person-group><article-title>Identification of six new polymorphisms in the human coronavirus 229E receptor gene (aminopeptidase N/CD13)</article-title><source>Int J Infect Dis</source><year>2004</year><volume>8</volume><fpage>217</fpage><lpage>222</lpage><pub-id pub-id-type="pmcid">PMC7129141</pub-id><pub-id pub-id-type="pmid">15234325</pub-id><pub-id pub-id-type="doi">10.1016/j.ijid.2004.03.004</pub-id></element-citation></ref><ref id="R73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vlasova</surname><given-names>AN</given-names></name><name><surname>Diaz</surname><given-names>A</given-names></name><name><surname>Damtie</surname><given-names>D</given-names></name><name><surname>Xiu</surname><given-names>L</given-names></name><name><surname>Toh</surname><given-names>T-H</given-names></name><name><surname>Lee</surname><given-names>JS-Y</given-names></name><name><surname>Saif</surname><given-names>LJ</given-names></name><name><surname>Gray</surname><given-names>GC</given-names></name></person-group><article-title>Novel Canine Coronavirus Isolated from a Hospitalized Pneumonia Patient, East Malaysia</article-title><source>Clin Infect Dis</source><year>2021</year><pub-id pub-id-type="pmcid">PMC8194511</pub-id><pub-id pub-id-type="pmid">34013321</pub-id><pub-id pub-id-type="doi">10.1093/cid/ciab456</pub-id></element-citation></ref><ref id="R74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walls</surname><given-names>AC</given-names></name><name><surname>Tortorici</surname><given-names>MA</given-names></name><name><surname>Bosch</surname><given-names>BJ</given-names></name><name><surname>Frenz</surname><given-names>B</given-names></name><name><surname>Rottier</surname><given-names>PJM</given-names></name><name><surname>DiMaio</surname><given-names>F</given-names></name><name><surname>Rey</surname><given-names>FA</given-names></name><name><surname>Veesler</surname><given-names>D</given-names></name></person-group><article-title>Cryo-electron microscopy structure of a coronavirus spike glycoprotein trimer</article-title><source>Nature</source><year>2016a</year><volume>531</volume><fpage>114</fpage><lpage>117</lpage><pub-id pub-id-type="pmcid">PMC5018210</pub-id><pub-id pub-id-type="pmid">26855426</pub-id><pub-id pub-id-type="doi">10.1038/nature16988</pub-id></element-citation></ref><ref id="R75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walls</surname><given-names>AC</given-names></name><name><surname>Tortorici</surname><given-names>MA</given-names></name><name><surname>Frenz</surname><given-names>B</given-names></name><name><surname>Snijder</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>W</given-names></name><name><surname>Rey</surname><given-names>FA</given-names></name><name><surname>DiMaio</surname><given-names>F</given-names></name><name><surname>Bosch</surname><given-names>BJ</given-names></name><name><surname>Veesler</surname><given-names>D</given-names></name></person-group><article-title>Glycan shield and epitope masking of a coronavirus spike protein observed by cryo-electron microscopy</article-title><source>Nat Struct Mol Biol</source><year>2016b</year><volume>23</volume><fpage>899</fpage><lpage>905</lpage><pub-id pub-id-type="pmcid">PMC5515730</pub-id><pub-id pub-id-type="pmid">27617430</pub-id><pub-id pub-id-type="doi">10.1038/nsmb.3293</pub-id></element-citation></ref><ref id="R76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walls</surname><given-names>AC</given-names></name><name><surname>Tortorici</surname><given-names>MA</given-names></name><name><surname>Snijder</surname><given-names>J</given-names></name><name><surname>Xiong</surname><given-names>X</given-names></name><name><surname>Bosch</surname><given-names>BJ</given-names></name><name><surname>Rey</surname><given-names>FA</given-names></name><name><surname>Veesler</surname><given-names>D</given-names></name></person-group><article-title>Tectonic conformational changes of a coronavirus spike glycoprotein promote membrane fusion</article-title><source>Proc Natl Acad Sci U S A</source><year>2017</year><volume>114</volume><fpage>11157</fpage><lpage>11162</lpage><pub-id pub-id-type="pmcid">PMC5651768</pub-id><pub-id pub-id-type="pmid">29073020</pub-id><pub-id pub-id-type="doi">10.1073/pnas.1708727114</pub-id></element-citation></ref><ref id="R77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walls</surname><given-names>AC</given-names></name><name><surname>Xiong</surname><given-names>X</given-names></name><name><surname>Park</surname><given-names>YJ</given-names></name><name><surname>Tortorici</surname><given-names>MA</given-names></name><name><surname>Snijder</surname><given-names>J</given-names></name><name><surname>Quispe</surname><given-names>J</given-names></name><name><surname>Cameroni</surname><given-names>E</given-names></name><name><surname>Gopal</surname><given-names>R</given-names></name><name><surname>Dai</surname><given-names>M</given-names></name><name><surname>Lanzavecchia</surname><given-names>A</given-names></name><etal/></person-group><article-title>Unexpected Receptor Functional Mimicry Elucidates Activation of Coronavirus Fusion</article-title><source>Cell</source><year>2019</year><volume>176</volume><fpage>1026</fpage><lpage>1039</lpage><elocation-id>e15</elocation-id><pub-id pub-id-type="pmcid">PMC6751136</pub-id><pub-id pub-id-type="pmid">30712865</pub-id><pub-id pub-id-type="doi">10.1016/j.cell.2018.12.028</pub-id></element-citation></ref><ref id="R78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walls</surname><given-names>AC</given-names></name><name><surname>Park</surname><given-names>YJ</given-names></name><name><surname>Tortorici</surname><given-names>MA</given-names></name><name><surname>Wall</surname><given-names>A</given-names></name><name><surname>McGuire</surname><given-names>AT</given-names></name><name><surname>Veesler</surname><given-names>D</given-names></name></person-group><article-title>Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein</article-title><source>Cell</source><year>2020a</year><volume>181</volume><fpage>281</fpage><lpage>292</lpage><elocation-id>e6</elocation-id><pub-id pub-id-type="pmcid">PMC7102599</pub-id><pub-id pub-id-type="pmid">32155444</pub-id><pub-id pub-id-type="doi">10.1016/j.cell.2020.02.058</pub-id></element-citation></ref><ref id="R79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walls</surname><given-names>AC</given-names></name><name><surname>Fiala</surname><given-names>B</given-names></name><name><surname>Schäfer</surname><given-names>A</given-names></name><name><surname>Wrenn</surname><given-names>S</given-names></name><name><surname>Pham</surname><given-names>MN</given-names></name><name><surname>Murphy</surname><given-names>M</given-names></name><name><surname>Tse</surname><given-names>LV</given-names></name><name><surname>Shehata</surname><given-names>L</given-names></name><name><surname>O’Connor</surname><given-names>MA</given-names></name><name><surname>Chen</surname><given-names>C</given-names></name><etal/></person-group><article-title>Elicitation of Potent Neutralizing Antibody Responses by Designed Protein Nanoparticle Vaccines for SARS-CoV-2</article-title><source>Cell</source><year>2020b</year><volume>183</volume><fpage>1367</fpage><lpage>1382</lpage><elocation-id>e17</elocation-id><pub-id pub-id-type="pmcid">PMC7604136</pub-id><pub-id pub-id-type="pmid">33160446</pub-id><pub-id pub-id-type="doi">10.1016/j.cell.2020.10.043</pub-id></element-citation></ref><ref id="R80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walls</surname><given-names>AC</given-names></name><name><surname>Miranda</surname><given-names>MC</given-names></name><name><surname>Pham</surname><given-names>MN</given-names></name><name><surname>Schäfer</surname><given-names>A</given-names></name><name><surname>Greaney</surname><given-names>A</given-names></name><name><surname>Arunachalam</surname><given-names>PS</given-names></name><name><surname>Navarro</surname><given-names>M-J</given-names></name><name><surname>Tortorici</surname><given-names>MA</given-names></name><name><surname>Rogers</surname><given-names>K</given-names></name><name><surname>O’Connor</surname><given-names>MA</given-names></name><etal/></person-group><article-title>Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines</article-title><source>bioRxiv</source><year>2021</year><pub-id pub-id-type="pmcid">PMC8440233</pub-id><pub-id pub-id-type="pmid">34619077</pub-id><pub-id pub-id-type="doi">10.1016/j.cell.2021.09.015</pub-id></element-citation></ref><ref id="R81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>RY</given-names></name><name><surname>Song</surname><given-names>Y</given-names></name><name><surname>Barad</surname><given-names>BA</given-names></name><name><surname>Cheng</surname><given-names>Y</given-names></name><name><surname>Fraser</surname><given-names>JS</given-names></name><name><surname>DiMaio</surname><given-names>F</given-names></name></person-group><article-title>Automated structure refinement of macromolecular assemblies from cryo-EM maps using Rosetta</article-title><source>Elife</source><year>2016</year><volume>5</volume><pub-id pub-id-type="pmcid">PMC5115868</pub-id><pub-id pub-id-type="pmid">27669148</pub-id><pub-id pub-id-type="doi">10.7554/eLife.17219</pub-id></element-citation></ref><ref id="R82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wibmer</surname><given-names>CK</given-names></name><name><surname>Ayres</surname><given-names>F</given-names></name><name><surname>Hermanus</surname><given-names>T</given-names></name><name><surname>Madzivhandila</surname><given-names>M</given-names></name><name><surname>Kgagudi</surname><given-names>P</given-names></name><name><surname>Oosthuysen</surname><given-names>B</given-names></name><name><surname>Lambson</surname><given-names>BE</given-names></name><name><surname>de Oliveira</surname><given-names>T</given-names></name><name><surname>Vermeulen</surname><given-names>M</given-names></name><name><surname>van der Berg</surname><given-names>K</given-names></name><etal/></person-group><article-title>SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma</article-title><source>Nat Med</source><year>2021</year><pub-id pub-id-type="pmid">33654292</pub-id></element-citation></ref><ref id="R83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname><given-names>AHM</given-names></name><name><surname>Tomlinson</surname><given-names>ACA</given-names></name><name><surname>Zhou</surname><given-names>D</given-names></name><name><surname>Satkunarajah</surname><given-names>M</given-names></name><name><surname>Chen</surname><given-names>K</given-names></name><name><surname>Sharon</surname><given-names>C</given-names></name><name><surname>Desforges</surname><given-names>M</given-names></name><name><surname>Talbot</surname><given-names>PJ</given-names></name><name><surname>Rini</surname><given-names>JM</given-names></name></person-group><article-title>Receptor-binding loops in alphacoronavirus adaptation and evolution</article-title><source>Nat Commun</source><year>2017</year><volume>8</volume><fpage>1735</fpage><pub-id pub-id-type="pmcid">PMC5701055</pub-id><pub-id pub-id-type="pmid">29170370</pub-id><pub-id pub-id-type="doi">10.1038/s41467-017-01706-x</pub-id></element-citation></ref><ref id="R84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wrapp</surname><given-names>D</given-names></name><name><surname>McLellan</surname><given-names>JS</given-names></name></person-group><article-title>The 3.1-Angstrom Cryo-electron Microscopy Structure of the Porcine Epidemic Diarrhea Virus Spike Protein in the Prefusion Conformation</article-title><source>J Virol</source><year>2019</year><volume>93</volume><pub-id pub-id-type="pmcid">PMC6854500</pub-id><pub-id pub-id-type="pmid">31534041</pub-id><pub-id pub-id-type="doi">10.1128/JVI.00923-19</pub-id></element-citation></ref><ref id="R85"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>K</given-names></name><name><surname>Li</surname><given-names>W</given-names></name><name><surname>Peng</surname><given-names>G</given-names></name><name><surname>Li</surname><given-names>F</given-names></name></person-group><article-title>Crystal structure of NL63 respiratory coronavirus receptor-binding domain complexed with its human receptor</article-title><source>Proc Natl Acad Sci U S A</source><year>2009</year><volume>106</volume><fpage>19970</fpage><lpage>19974</lpage><pub-id pub-id-type="pmcid">PMC2785276</pub-id><pub-id pub-id-type="pmid">19901337</pub-id><pub-id pub-id-type="doi">10.1073/pnas.0908837106</pub-id></element-citation></ref><ref id="R86"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xiong</surname><given-names>X</given-names></name><name><surname>Tortorici</surname><given-names>MA</given-names></name><name><surname>Snijder</surname><given-names>J</given-names></name><name><surname>Yoshioka</surname><given-names>C</given-names></name><name><surname>Walls</surname><given-names>AC</given-names></name><name><surname>Li</surname><given-names>W</given-names></name><name><surname>McGuire</surname><given-names>AT</given-names></name><name><surname>Rey</surname><given-names>FA</given-names></name><name><surname>Bosch</surname><given-names>BJ</given-names></name><name><surname>Veesler</surname><given-names>D</given-names></name></person-group><article-title>Glycan Shield and Fusion Activation of a Deltacoronavirus Spike Glycoprotein Fine-Tuned for Enteric Infections</article-title><source>J Virol</source><year>2018</year><volume>92</volume><pub-id pub-id-type="pmcid">PMC5790929</pub-id><pub-id pub-id-type="pmid">29093093</pub-id><pub-id pub-id-type="doi">10.1128/JVI.01628-17</pub-id></element-citation></ref><ref id="R87"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xiu</surname><given-names>L</given-names></name><name><surname>Binder</surname><given-names>RA</given-names></name><name><surname>Alarja</surname><given-names>NA</given-names></name><name><surname>Kochek</surname><given-names>K</given-names></name><name><surname>Coleman</surname><given-names>KK</given-names></name><name><surname>Than</surname><given-names>ST</given-names></name><name><surname>Bailey</surname><given-names>ES</given-names></name><name><surname>Bui</surname><given-names>VN</given-names></name><name><surname>Toh</surname><given-names>T-H</given-names></name><name><surname>Erdman</surname><given-names>DD</given-names></name><etal/></person-group><article-title>A RT-PCR assay for the detection of coronaviruses from four genera</article-title><source>J Clin Virol</source><year>2020</year><volume>128</volume><elocation-id>104391</elocation-id><pub-id pub-id-type="pmcid">PMC7192118</pub-id><pub-id pub-id-type="pmid">32403008</pub-id><pub-id pub-id-type="doi">10.1016/j.jcv.2020.104391</pub-id></element-citation></ref><ref id="R88"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>P</given-names></name><name><surname>Yang</surname><given-names>XL</given-names></name><name><surname>Wang</surname><given-names>XG</given-names></name><name><surname>Hu</surname><given-names>B</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>W</given-names></name><name><surname>Si</surname><given-names>HR</given-names></name><name><surname>Zhu</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>B</given-names></name><name><surname>Huang</surname><given-names>CL</given-names></name><etal/></person-group><article-title>A pneumonia outbreak associated with a new coronavirus of probable bat origin</article-title><source>Nature</source><year>2020</year><pub-id pub-id-type="pmcid">PMC7095418</pub-id><pub-id pub-id-type="pmid">32015507</pub-id><pub-id pub-id-type="doi">10.1038/s41586-020-2012-7</pub-id></element-citation></ref><ref id="R89"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zivanov</surname><given-names>J</given-names></name><name><surname>Nakane</surname><given-names>T</given-names></name><name><surname>Forsberg</surname><given-names>BO</given-names></name><name><surname>Kimanius</surname><given-names>D</given-names></name><name><surname>Hagen</surname><given-names>WJ</given-names></name><name><surname>Lindahl</surname><given-names>E</given-names></name><name><surname>Scheres</surname><given-names>SH</given-names></name></person-group><article-title>New tools for automated high-resolution cryo-EM structure determination in RELION-3</article-title><source>Elife</source><year>2018</year><volume>7</volume><pub-id pub-id-type="pmcid">PMC6250425</pub-id><pub-id pub-id-type="pmid">30412051</pub-id><pub-id pub-id-type="doi">10.7554/eLife.42166</pub-id></element-citation></ref><ref id="R90"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zivanov</surname><given-names>J</given-names></name><name><surname>Nakane</surname><given-names>T</given-names></name><name><surname>Scheres</surname><given-names>SHW</given-names></name></person-group><article-title>A Bayesian approach to beam-induced motion correction in cryo-EM single-particle analysis</article-title><source>IUCrJ</source><year>2019</year><volume>6</volume><fpage>5</fpage><lpage>17</lpage><pub-id pub-id-type="pmcid">PMC6327179</pub-id><pub-id pub-id-type="pmid">30713699</pub-id><pub-id pub-id-type="doi">10.1107/S205225251801463X</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="F1" position="float"><label>Figure 1</label><caption><title>Architecture of the CCoV-HuPn-2018 infection machinery.</title><p><bold>A,</bold> Schematic diagram of the S glycoprotein organization. Dashed lines and grey boxes denote regions unresolved in the reconstruction and regions that were not part of the construct, respectively. UH, upstream helix; FP, fusion peptide; HR1, heptad-repeat 1; CH, central helix; BH, β-hairpin; CD: connector domain; HR2, heptad-repeat 2; TM, transmembrane domain; CT, cytoplasmic tail. <bold>B-C,</bold> CryoEM structure of the CCoV-HuPn-2018 S ectodomain trimer (with each domain 0 swung out) viewed along two orthogonal orientations. <bold>D-E,</bold> CryoEM structure of the CCoV-HuPn-2018 S ectodomain trimer (with each domain 0 pointing ‘proximal’ toward the viral membrane) viewed along two orthogonal orientations. <bold>F-G,</bold> Ribbon diagram of the CCoV-HuPn-2018 S<sub>1</sub> subunit with domain 0 in the swung out (F) and proximal (G) conformations. <bold>H,</bold> Superimposition of the S<sub>1</sub> subunit from the structures with domain 0 in the swung out (light blue) and proximal (pink) conformations showing the A domain moving away from the B domain of the same protomer and rotation of domain 0. <bold>I,</bold> Western blot of VSV pseudotyped particles harboring HCoV-229E S, CCoV-HuPn-2018 S, SARS-CoV-2 S or MERS-CoV S. Mw: molecular weight ladder. Full-length S and S<sub>2</sub> subunit bands are indicated on the right hand side of the blot.</p></caption><graphic xlink:href="EMS162965-f001"/></fig><fig id="F2" position="float"><label>Figure 2</label><caption><title>Structural conservation of CCoV-HuPn-2018 S domain 0 and domain</title><p><bold>A. A-C,</bold> Ribbon diagrams of the CCoV-HuPn-2018 S domain 0 (A) and domain A (B) oriented as shown in the prefusion S conformation shown in (C). <bold>D,</bold> Sequence alignment of CCoV-HuPn-2018 S domain A and domain 0 highlighting the low sequence identity (12.5%) between them. <bold>E-G,</bold> Topology diagrams of domain 0 (E) and domain A (F) and structural overlay between the two domains (G) underscoring their similarity. N-linked glycans are rendered as blue spheres in panels (A-C) but were removed from panel G for clarity.</p></caption><graphic xlink:href="EMS162965-f002"/></fig><fig id="F3" position="float"><label>Figure 3</label><caption><title>The CCoV-HuPn-2018 S B domain recognizes APN.</title><p><bold>A-C,</bold> Ribbon diagrams of the CCoV-HuPn-2018 B domain (A), the PRCV B domain bound to porcine APN (PDB: 4F5C) (B) and overlay (C) underscoring their structural similarity. N-linked glycans are rendered as blue spheres. <bold>D-K,</bold> Biolayer interferometry kinetic binding analysis of feline (D,H), canine (E,I), porcine (F,J) and human (G,K) monomeric APN ectodomains to biotinylated CCoV-HuPn-2018 B domain (D-G) or TGEV B domain (H-K) immobilized at the surface of SA biosensors.</p></caption><graphic xlink:href="EMS162965-f003"/></fig><fig id="F4" position="float"><label>Figure 4</label><caption><title>APN is a functional entry receptor for CCoV-HuPn-2018.</title><p><bold>A-C,</bold> Entry of VSV particles pseudotyped with the CCoV-HuPn-2018 S (A), TGEV S (B) and HCoV-V229E S (C) in HEK293T cells transiently transfected with canine, feline, porcine, human or human R741T (glycan knockin) APN orthologs. RLU: relative luciferase units. <bold>D-F</bold>, Entry of VSV particles pseudotyped with the CCoV-HuPn-2018 S (D), TGEV S (E) and HCoV-V229E S (F) in HEK293T cells transiently transfected with human R741T (glycan knockin), canine, feline, or porcine APN orthologs with or without TMPRSS2. <bold>E,</bold> Concentration-dependent inhibition of CCoV-HuPn-2018 S pseudovirus entry in HEK293T cells transiently transfected with full-length APN orthologs with matched, purified dimeric soluble APN-Fc ectodomains. <bold>H,</bold> Sequence alignment of human, feline, canine, and porcine APNs focused on the N739 glycosylation sequon. Human APN position 741 is indicated with an asterisk.</p></caption><graphic xlink:href="EMS162965-f004"/></fig><fig id="F5" position="float"><label>Figure 5</label><caption><title>Evaluation of polyclonal and monoclonal antibody neutralization of CCoV-HuPn-2018 S-mediated entry.</title><p><bold>A-B</bold>, Sequence conservation of HCoV-229E, HCoV-NL63 and CCoV-HuPn-2018 S glycoproteins plotted on the CCoV-HuPn-2018 S structure viewed from the side (A) and top (B). The sequence alignment was generated using the following sequences: CCoV-HuPn-2018 S (QVL91811.1), HCoV-229E S (AAK32191.1 and ABB90515) and HCoV-NL63 S (AIW52835.1 and YP_003767.1). <bold>C-E,</bold> CCoV-HuPn-2018 S (C), TGEV S (D) and HCoV-229E S (E) pseudotyped virus entry in the presence of a 1:5 diluted plasma obtained between 1985 and 1987 from human subjects previously infected with HCoV-229E (Full neutralization curves are shown in <xref ref-type="supplementary-material" rid="SD1">Figure S6</xref>). <bold>F-G</bold> CCoV-HuPn-2018 S (F) and TGEV S (G) pseudotyped virus entry in the presence of various concentrations of 1AF10 neutralizing monoclonal Fab in HEK293T cells transfected with the indicated full-length APN orthologs. <bold>H-I,</bold> Competition between 1AF10 Fab and APN for binding to immobilized CoV-HuPn-2018 (H) or TGEV (I) B domains analyzed by biolayer interferometry. Each CoV-HuPn-2018 (H) or TGEV (I) B domain-loaded SA biosensor was sequentially dipped in a solution containing 10X above the measured affinity (<xref ref-type="supplementary-material" rid="SD1">Table S3</xref>) with 170 or 100 nM 1AF10 Fab respectively and then 170 or 100 nM 1AF10 Fab + 10 or 21 nM canine (orange), 270 or 470nM feline (grey), 410 or 700nM porcine (pink) APN monomeric or 170 or 100 nM 1AF10 Fab alone (blue).</p></caption><graphic xlink:href="EMS162965-f005"/></fig></floats-group></article>